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1SUMMARY
The studies reported in this thesis were undertaken to 
explore ways in which an improved vaccine could be developed 
against the disease caused by the cattle lungworm Dictyocaulus 
viviparus.
The current vaccine is a live, non-sterile, oral preparation 
of x-irradiated larvae, although more recently a gamma-irradiated 
oral vaccine has been marketed in the Netherlands and the U.K. 
Each is administered orally in two doses 28 days apart.
It was thought that it would be advantageous from the 
viewpoint of future licensing requirements, if live vaccine could 
be rendered microbiologically sterile and that certain commercial 
benefits could be obtained from packaging the vaccine in plastic 
rather than glass bottles.
The first experimental chapter, Chapter Three, deals with 
the problems of producing a sterile suspension of larvae without 
harming their viability or infectivity. A suitable means of 
achieving this was found to be a one hour treatment with a 
0.0024% w/v solution of the monosodium salt of 5,5f-Dichloro- 
2 ,2 '-dihydroxydiphenylmethane (dichlorophen).
Chapter Four is concerned with the packaging of vaccine in 
plastic bottles. The main problem in this respect was that in 
, earlier studies a large proportion of the larvae were found to 
adhere to the surface of the bottle and in consequence were not 
delivered to the calf at dosing. However, various newer plastics 
were examined in the present work and polyethylene tetraphthalate 
(P.E.T.) was found to give results comparable to glass.
As a stepping-stone towards the use of a killed antigen
2extract as a vaccine, it was thought possible that, in a two dose 
vaccine, the initial dose could remain as the current oral 
preparation and be followed up with an injection of killed larval 
extract 28 days later. This regime was investigated in Chapter 
Five and, in the method attempted, gave poor protection against 
subsequent challenge.
Now that it was possible to render the irradiated larvae 
sterile, it was considered feasible to investigate the 
immunogenicity of parenterally administered irradiated larvae. 
The experiments on this aspect are presented in Chapter Six. It 
was found that subcutaneous administration of two doses of 
irradiated larvae 4 weeks apart gave 95% protection against 
experimental challenge.
In the concluding experimental chapter, Chapter Seven, the 
use of sterile, injectable vaccine was further studied and the 
process of sterilising the larval suspension simplified and 
refined. In addition, the required evidence of safety, efficacy 
and sterility was acquired in preparation for an application to 
be made for a Ministry of Agriculture certificate to permit field 
testing of this new formulation of bovine lungworm vaccine.
Chapter One.
General Introduction.
4Taxonomy of the genus Dictyocaulus.
Species of the genus Dictyocaulus, Railliet & Henry, 1 907, 
are parasitic phasmid nematodes which occur in the respiratory 
passages of certain ungulates.
The exact taxonomic position of the genus has been a matter 
of some debate. Soulsby (1968) and Dunn (1978) base their 
classification on the work of Skrjabin. In this system the genus 
is placed in the family Dictyocaulidae, Skrjabin, 1941 under the 
superfamily Trichostrongyloidea, Cram, 1927. Soulsby further 
assigns this superfamily to the suborder Strongylata, Railliet & 
Henry, 1913 under the Order Rhabditida, Chitwood, 1933. Dunn, 
however, raises the suborder to order status as the Strongylida. 
Smyth (1976) takes a different view and bases his classification 
on the work of Chitwood. Here, as in Dunn, the order is 
Strongylida but the genus Dictyocaulus is placed in the family 
Metastrongylidae, Leiper, 1908.
The principal difference between the Skrjabin and the 
Chitwood systems is whether the genus should be classified along 
with nematodes with a similar, non-parasitic phase outside the 
final host, or with those sharing a similar, pulmonary location 
in the final host.
In both classifications, the trichostrongyloid families 
typically have direct life-cycles employing no intermediate 
hosts. They are also non-migratory in their parasitic phase and 
lay unlarvated eggs. In contrast, typical metastrongylid genera, 
except Dictyocaulus, have indirect life-cycles utilising annelids 
or molluscs as intermediate hosts. In the final host they are 
all migratory, the majority of genera having their adult stage in
5the lungs. They are also all ovo-viviparous with the solitary 
exception of Metastrongylus spp. which are oviparous.
The genus Dictyocaulus has a direct life-cycle as befitting 
a trichostrongyloid, yet these species are migratory, live in the 
lungs and are ovo-viviparous as are the metastrongylids. The 
genus can, therefore, be the only lung-dwelling, ovo-viviparous 
trichostrongyloid or it can be one of the few metastrongylids 
with a direct life-cycle.
Four species of Dictyocaulus are known: D.viviparus, Bloch 
1782, is found in bovines, buffaloes and the Cervidae; D.filaria, 
Rudolphi 1809, in sheep and goats; D.amfieldi, Cobbold 1884, in 
the Equidae and D.cameli, Boev 1952, in the camel.
Synonyms of D.viviparus used in the past include : 
Gordius viviparus, Bloch, 1782; Strongylus vitulorum, Rudolphi, 
1809 and Strongylus micrurus, Mehlis, 1831. D.eckerti reported 
from the cervidae is now also thought to be synonymous with 
D.viviparus (Dunn, personal communication).
6The Life-cycle of Dictyocaulus viviparus in Cattle.
Under natural conditions, infection with 
Dictyocaulus viviparus is initiated by the ingestion of 
ensheathed third-stage larvae (L3 ) from contaminated pasture 
while grazing (Daubney 1920). Since the larvae exsheath readily 
under the stimulus of hypochlorite, it is assumed that they 
exsheath in the rumen and penetrate the wall of the small 
intestine (Smythe,1937; Jarrett, McIntyre, Jennings and Mulligan, 
1957a; Poynter, Jones, Nelson, Peacock, Robinson, Silverman and 
Terry, 1960). These then, according to most authors, enter the 
lymphatic vessels and are carried to the mesenteric lymph nodes. 
Here the L3 moults to become the L4 (Smythe 1937). It is 
presumed that the L4 is carried with the flow of lymph to the 
thoracic duct where it enters the blood-stream in the jugular 
vein. The blood-stream takes the larvae through the right heart 
and the pulmonary artery to the capillary beds of the lungs. Here 
they break out of the capillaries into the alveoli. The larvae 
then migrate up the respiratory tract. During this period they 
make their final moult and the adults are found in the larger 
bronchioles, the bronchi and the trachea (see Fig. 1.1). The 
adult males and females mate and larvated eggs are laid (Cobbold, 
1886). The eggs are passed up the trachea by a combination of 
the ciliary/mucus movement and the animal's cough. They are then 
swallowed and are voided with the faeces. By the time they have 
passed through the alimentary tract the eggs have hatched and 
thus it is the L-| which arrives on the pasture (see Fig. 1.2).
Unlike the free-living stages of the trichostrongyloid 
parasites, larvae of the genus Dictyocaulus apparently do not
7feed (Daubney, 1920), However, their intestinal cells are filled 
with granules which are thought to be composed of lipid and 
provide an energy source.
The larvae of Dictyocaulus spp. are slow-moving in 
comparison to those of the trichostrongyloids. The L2 is reached 
in one or two days but the cuticle is not shed. Under optimum 
conditions of 27°C and 95% humidity the infective L3 is reached 
in about one week (Daubney 1920). This development is slower at 
lower temperatures (Rose, 1956). The L3 retains both the and 
the L2  sheaths although the cuticle is sometimes lost through 
mechanical damage.
8Fig. 1.1.
Coiled thread-like masses of adult Dictyocaulus viviparus 
and frothy mucus in the bronchus of a diaphragmatic lobe.
9Fig. 1.2.
Characteristic appearance of first stage Dictyocaulus 
viviparus larvae.
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The Pathogenesis of Dictyocaulus viviparus Infection.
The pathology of lungworm disease has been the subject of a 
great deal of study and is described in detail in many 
publications. The description given here is based on the work 
of : Jarrett et al. (1957a); Jarrett, McIntyre and Urquhart 
(1957b); Simpson, Wade, Dennis and Swanson (1957); Jarrett, 
Jennings, McIntyre, Mulligan, Sharp and Urquhart (1960a); 
Poynter et al. (1960); and Pirie, Doyle, McIntyre and Armour 
(1971).
The severity of clinical signs which develop from an 
infection with D.viviparus depend on several parameters, the most 
important being the size of the infecting dose of larvae and 
whether or not the animal has been previously exposed to lungworm 
infection. Less important but significant are the animal's age, 
its size and possibly its nutritional state.
Jarrett et al. (1960a) divided the disease into four 
phases : penetration; prepatent; patent and postpatent.
The penetration phase is from the day of initial ingestion 
of infective larvae (day 0) to day 7. During this time the 
larvae penetrate the gut wall and migrate via the lymphatics and 
heart to the lungs. During this phase clinical signs are not 
apparent.
The prepatent phase lasts from day 8  to patency at around 
day 25. During this period the larvae appear in the alveoli and 
move up the bronchioles to the bronchi. Their presence causes 
inflammation typified by an influx of eosinophils, neutrophils, 
macrophages and multinucleated giant cells into the lumina of the 
alveoli and in the bronchioles these cells form plugs. This
11
blockage prevents inspired air reaching the lung tissue distal to 
the plug and these areas collapse. The bronchiolar walls, the 
connective tissues and the interlobular septa all become packed 
with inflammatory cells, mainly eosinophils. The bronchioles may 
become ruptured leading to interstitial emphysema. The emphysema 
makes expiration painful thus causing an inhibition of normal 
lung contraction. In heavy infections the dyspnoea coupled with 
the alveolar collapse leads to a state of anoxia which impairs 
normal heart function. This in turn leads to pulmonary oedema 
and then the formation of hyaline membranes, further reducing the 
respiratory surface and increasing the anoxia. In acute cases 
the anoxic dyspnoea and heart failure can cause death from Day 15 
onwards and before adult worms are present in the lungs.
From around day 26 adult worms are present in the bronchi. 
These produce eggs detectable as L-| in the faeces. The disease 
has thus reached patency. The adults cause bronchitis with an 
influx of inflammatory cells into the epithelium and lamina 
propria of the bronchi. This leads to a thickening and 
hyperplasia of the bronchial epithelium. Frothy, white mucus 
containing eggs, first-stage larvae, adult worms, epithelial 
cells and leucocytes is present on the bronchial mucosa. Extreme 
hyperplasia of the epithelium of the bronchioles plus an influx 
of neutrophils and eosinophils may block the passage of inspired 
air into the alveoli. As with the prepatent phase, interstitial 
emphysema at this stage can severely affect the breathing 
efficiency. In the alveoli there is a cellular infiltration of 
neutrophils, eosinophils, macrophages and giant cells. This is
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in response to the aspiration of eggs and larvae (see Fig. 1.3) 
and, coupled with the collapse of the alveoli, leads to large 
areas of consolidation in the lungs (see Fig. 1.4). The majority 
of lungworm deaths occur in this phase and for the surviving 
animals the symptoms may start to decrease from day 35.
In untreated cases the post-patent phase of the disease is 
from day 60 onwards to about 13 weeks. Around day 60 the adult 
worms are expelled and the lesions regress. For 75% of the 
clinical cases the post-patent phase is simply a recovery period. 
There continues to be a cellular infiltration into the alveoli 
and bronchioles until all the worm debris has been removed. 
However, the epithelial hyperplasia remains and areas of fibrosis 
may be present. Complete recovery, at least clinically, 
eventually takes place although this may take several months.
In the remaining 25% of post-patent cases there is a sudden 
worsening of signs. This is due to a proliferative alveolitis 
characterised by a proliferation of type-2 pneumocytes on the 
alveolar epithelium. This is often, also, accompanied by 
interstitial emphysema, pulmonary oedema and hyaline membrane 
formation as described in pre-patent husk. Such cases usually 
die.
After repeated light infections calves develop a strong 
immunity to the disease. However, in response to a large 
challenge the immune response itself can cause clinical signs. 
This is known as the reinfection syndrome. The lesion starts as 
a necrotising bronchiolitis accompanied by a marked eosinophil 
infiltrate. This gradually regresses and eventually a lymphoid 
nodule forms around the dead larvae in the lungs (see Fig. 1.5).
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This lesion causes temporary obstruction of the bronchioles 
resulting in coughing. It is rarely fatal as the lesion quickly 
resolves.
Occasionally, however, patent parasitic bronchitis is 
observed in adult cattle in circumstances where they have not 
been exposed to infections as calves and therefore have not 
developed immunity.
14
Fig. 1.3.
Aspirated eggs and first-stage larvae in the alveoli 
associated with cellular infiltration of neutrophils/ 
eosinophils, macrophages and giant cells.
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Fig. 1.4.
Typical areas of pulmonary consolidation in the 
diaphragmatic lobes associated with patent parasitic bronchitis. 
This is largely caused by the lesion shown in the previous 
figure.
16
Fig. 1.5.
Small lymphoid nodule on the pleural surface of the lung. 
This cellular reaction arises as a response to the death of a 
larva in the lungs of an immune animal.
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The Epidemiology of Husk.
Clinical dictyocauliasis is largely a product of intensive 
grazing systems. In contrast, it is possible that if cattle 
lived as wild ruminants, the disease would rarely occur (Peacock 
& Poynter, 1980). The closest domestic example to wild existence 
is the spring-born beef-suckler calf. Such a calf tends to run 
with its dam on extensive grazing and gradually weans itself 
between four and eight months old. During this period the calf 
is increasing its intake of herbage and Dictyocaulus larvae and 
developing an acquired immunity. Under such circumstances the 
calf is unlikely to develop clinical husk before it is weaned in 
October by which time it is usually fully immune. This scenario 
is visualised by Taylor (1960) as " a group of red Hereford cows, 
with calves at foot, grazing the green infected grass, where they 
pick up infection and grow fat ".
In direct contrast to this picture is the dairy calf. In 
modem dairy systems the calf is removed from its mother as early 
as possible and pail fed until it is 5 to 7 weeks old. When such 
a calf is turned out at 3 - 4 months old, it is totally dependent 
on eating grass (see Fig. 1.6). If the grass is contaminated with 
lungworm larvae it will quickly pick up a large infection and 
since it has had no chance to acquire any immunity it will 
possibly contract severe parasitic bronchitis.
It must not be assumed, however, that lungworm outbreaks are 
confined solely to dairy herds. The autumn-born suckler calf is 
also at risk. Such a calf typically spends the important weaning 
period indoors where it will not experience a gradually 
increasing lungworm challenge. When turned out in the spring it
18
is, like the dairy calf, totally dependent on grass and 
immunologically, totally naive.
Infective larvae survive longest in cool damp conditions 
(Porter, 1942, Rose, 1956). In temperate climates larvae passed 
in faeces in the autumn can still be present on the pasture in 
the following spring (Jarrett, McIntyre & Urquhart, 1954, Jarrett, 
McIntyre, Urquhart & Bell, 1955b, Allan & Baxter, 1957). While 
the actual bionomics preceding the onset of clinical signs is 
unknown, it has been suggested that, as is the case with 
Ostertagia infections, a light overwintered pasture infestation 
leads eventually to a build up of infection during the summer 
months. Others, in an effort to explain outbreaks, have 
suggested that larvae migrate into the soil in autumn to re- 
emerge in the spring and summer (Nelson, 1977). This migration 
is probably helped by the larvae being transported downwards by 
earthworms (Oakley, 1981) and dung beetles (Fincher, 1973) which 
have fed under the crust of the faecal pat.
It has also been shown that larvae which experience a 
prolonged period of chilling prior to ingestion may inhibit at 
the L4 or L5 stage (Taylor & Michel, 1952, Michel, 1955a, Oakley, 
1979). Such inhibited forms possibly recommence their 
development throughout the winter and thus cause pasture 
contamination in the spring (Pfeiffer & Supperer, 1973).
In Britain, larvae which overwinter on the pasture are 
thought to be an important source of infection in the spring 
(Allen & Baxter, 1957, Burger, 1978, Oakley, 1978, Duncan, 
Armour, Bairden, Urquhart & Jorgensen, 1979). In colder regions,
such as the alpine areas of Europe, where survival on pasture is 
thought to be less common (Pfeiffer & Supperer, 1973), inhibited 
larvae are thought to be the more important source (Pfeiffer & 
Supperer, 1 980). By one or a combination of these means larvae 
are present on the pasture in spring. These give rise to very 
light infections which cause few clinical signs and little 
immunity but which do, however, lead to an increase in pasture 
contamination. This reseeding may be aided by fresh 
contamination with larvae voided by older cattle acting as 
carriers (Cunningham, Jarrett, McIntyre & Urquhart, 1956) or by 
larvae reappearing from the deeper layers of the soil (Nelson, 
1977). Thus the pasture larval burden is high enough by June or 
July to give rise to outbreaks of clinical disease in July to 
September.
Cattle are known to avoid the grass around faecal pats 
(Michel, 1955b) so that for efficient transmission the larvae 
must migrate as far from the pat as possible. Dictyocaulus 
larvae are sluggish in comparison to the infective larvae of the 
trichostrongyloids and probably do not leave the pat by their own 
movement (Michel & Rose, 1954). Instead they rely on mechanical 
translation (by means of rain splash, tractor wheels, hooves 
etc.) and their special relationship with the coprophagous fungus 
Pilobolus (Robinson, 1962). This fungus grows on the surface of 
the faecal pat from spores which have passed through the bovine 
alimentary tract. To facilitate the ingestion of spores, the 
sporangium explodes violently, discharging spores onto the 
surrounding herbage (see Fig. 1.7). Dictyocaulus larvae take 
advantage of Pilobolus by climbing into the sporangium
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(Doncaster, 1981) (see Fig.1.8). On dehiscence the larvae are 
thrown along with the spores away from the faecal pat. By this 
means larvae can travel considerable distances especially if the 
airborne spores and larvae are caught by the wind.
For these two reasons no pasture in an endemic area can be 
thought of as "clean" - outbreaks of husk even having been 
reported from aftermath pasture (Armour, Al Saqur, Bairden, 
Duncan & Urquhart, 1980).
Taylor (1960) discussed some of the epidemiological 
questions raised by the use of the lungworm vaccine (Dictol, 
Glaxo Animal Health). He suggested that vaccinated calves should 
be kept away from heavily infected pastures, that vaccinates, 
after challenge, could act as immune carriers and that 
vaccination would never eradicate lungworm disease. While these 
suggestions were based on epidemiological theory rather than 
observation he was shown to be correct on all counts.
Cornwell (1959) and Cornwell & Berry (1960) reported an 
outbreak of husk in unvaccinated calves which had been initiated 
by vaccinated calves from another farm apparently, after field 
challenge, acting as immune carriers. Cornwell (1962a) 
subsequently studied 134 vaccinated calves. He noted that 
vaccinated calves could be killed by receiving too great a 
challenge and presumed that this was due to a severe lung 
reaction to dead or dying worms. However, he also pointed out 
that if all calves on a farm were vaccinated, such a high 
challenge would not arise. He suggested that it was desirable 
for all calves to receive some challenge to keep immunity at a
21
sufficient level and that this would almost certainly occur since 
all the vaccinates that he observed on pasture excreted larvae at 
some point following challenge. A low level of infection would 
cycle in the vaccinated herd without reaching levels where calves 
would die of a severe challenge and without pasture infestation 
being completely eliminated.
22
Fig. 1.6.
Typical paddock adjacent to farm buildings commonly used 
annually to graze young calves in early summer. Such paddocks 
are often a perennial source of lungworm infection, due mainly to 
the presence of overwintered larvae.
23
Fig. 1.7.
Pilobolus spp. fungus growing on the surface of the bovine 
faecal pat.
24
Fig. 1.8.
Close-up of a mature Pilobolus sporangium and proximal 
hypha, showing the presence of Dictyocaulus viviparus larvae on 
the latter.
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Treatment and Control of Lungworm Infection.
The sucessful treatment of cases of clinical husk has long 
been a problem for the practitioner. Nicholls (1755) advocated 
fumigation with mercurials or tobacco. Smythe (1937), while 
admitting that " the value of all treatments ... has lain in 
their inefficiency" was of the opinion that intra-tracheal 
injections of oleum chaenopodii or pyrethrum in oil were the best 
available.
Gibson (1975) and Armour and Bogan (1982) have reviewed the 
recent history of anthelmintic medication. The drug of choice in 
the early 1 960s was diethylcarbamazine citrate. This drug was 
more effective in prepatent cases. It was usually administered 
by intra-muscular injection daily on three consecutive days.
Diethylcarbamazine has since been superseded by levamisole 
and the benzimidazoles. Levamisole has proved to be an efficient 
drug against developing larvae, adults and even inhibited larvae. 
Of the benzimidazoles, fenbendazole, albendazole and oxfendazole 
have proved effective although only fenbendazole, to date, has 
been shown to have any action against arrested forms of 
Dictyocaulus viviparus.
In any outbreak of parasitic bronchitis, while only one or 
two animals may be clinically ill, the rest of the calves may 
have the disease in the early prepatent phase. In such an 
instance it may be desirable to treat the whole herd 
to pre-empt the appearance of clinical signs. In the treament of 
adult dairy cattle, the choice of anthelmintic will be limited to 
those which are licensed for use in the lactating animal. In this 
respect only levamisole and fenbendazole are of practical use.
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Even in use of these, milk cannot be sold for human consumption 
during a period of one day for levamisole, or three days for 
fenbendazole, following treatment.
McEwan, Oakley & Robinson (1979) compared levamisole and 
fenbendazole in the treatment of experimental husk. They 
reported that fenbendazole-treated animals showed more serious 
lesions than the levamisole treated group. These lesions were 
not associated with poor anthelmintic activity but it was 
postulated that these were reactions to adult worms dying in- 
situ. Fenbendazole kills the worms by preventing their 
absorption of nutrients, thus starving the worms in the lungs. 
In contrast, levamisole causes neuro-muscular paralysis in the 
worms and allows their clearance by muco-ciliary movement while 
still intact. McEwan, Oakley & Robinson (1979) therefore thought 
that only fenbendazole-killed worms released worm material into 
the lungs causing the severe reactions that they noted. However, 
Jarrett, Urquhart & Bairden (1980) found that both these drugs 
caused adverse reactions when used inl:he treatment of patent 
husk and related the degree of lung damage to the length of time 
between infection and treatment.
The prophylactic use of anthelmintics to prevent outbreaks 
of husk has never proved very successful. The fact that the 
bionomics of the parasite on pasture are poorly understood makes 
the calculation of the optimal time for prohylactic treatment 
impossible. The use of anthelmintics at three and six weeks after 
turn out has been shown to prevent the build-up on pasture of 
high levels of the infective larvae of the gastro-intestinal
27
pasrasites and therefore prevent outbreaks of parasitic gastro­
enteritis in mid-summer. Such a treatment regime has little value 
in the prevention of husk, possibly because infective larvae 
reappear on the pasture from the soil in mid-summer and also 
because low numbers of larvae on the herbage can cause clinical 
husk.
28
Irriruinity to Lungworm Infection.
The fact that cattle which survive an initial infection of 
Dictyocaulus viviparus are subsequently resistant to reinfection 
has been known for some years (Taylor 1951, Jarrett, McIntyre and 
Urquhart 1954) and has been reproduced experimentally (Porter & 
Cauthen, 1942; Rubin & Lucker, 1956; Jarrett, Jennings, McIntyre, 
Mulligan, Thomas & Urquhart, 1959b). The speed with which this 
immunity is acquired and its efficacy is quite unusual in 
helminth infections.
The reasons for this relative absence of effective immunity 
to nematodes generally, are closely linked to the successful 
exploitation of parasitism by this group. While these complex 
metazoan creatures could be expected to present a greater amount 
of potentially antigenic material to the host compared with 
microbial pathogens, it is apparent that their size renders such 
potent immunological mechanisms as agglutination, precipitation 
and opsonisation relatively ineffective. In addition, the fact 
that these parasites have several stages of their life-cycles 
within the host may enable them to change their external antigens 
before the host has had a chance to respond (Philipp, Parkhouse & 
Ogilvie, 1980). Furthermore, the nematode cuticle appears to be 
less immunogenic than the tegument of cestode parasites. This is 
not surprising in view of the complex metabolic functions of the 
tegument of the tapeworms in comparison with which the nematode 
cuticle is relatively inert. One point in the host's favour, 
however, is the fact that helminths (with a very few exceptions) 
do not multiply within the host and therefore cannot rely on a
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massive reproductive potential to outstrip an individual host's 
immune response.
In recent years the immunology of parasitic diseases in 
laboratory models has possibly been the most researched area of 
parasitology. However, despite the massive literature on the 
subject, little has been learned which adds to our knowledge of 
the mechanisms of immunity to D.viviparus infection. It is, 
perhaps, somewhat paradoxical that the only helminth infection 
for which a vaccine is commercially available is also one of the 
least understood from the point of view of the immune responses 
involved.
The bulk of the work on immunity to nematodes has been 
concerned with gastro-intestinal worms. In particular a great 
deal has been written about Nippostongylus brasiliensis and 
Trichinella spiralis in the rat (reviewed by Wakelin, 1984). 
Immunity to a primary infection of these parasites is typified by 
what is known as "immune expulsion" some days after the 
establishment of the worms. During immune expulsion adult worms 
are expelled from the intestine, often still alive. In response 
to a secondary infection fewer worms establish and immune 
expulsion occurs earlier (Jarrett, Jarrett & Urquhart 1968). The 
mechanisms involved in this phenomenon are still a matter of 
debate but appear to be associated with an IgE-mediated 
anaphylaxis (Ogilvie 1964). Mast cells in the intestinal mucosa 
increase in numbers and bind specific anti-worm IgE via the Fc 
receptor. When antigen binds to the IgE the mast cell 
degranulates releasing various factors including vaso-active 
amines. These cause an increase in mucosal permeability allowing
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plasma to leak into the gut lumen. In addition to involvement 
with mast cells, IgE may be instrumental in causing goblet cell 
hyperplasia with a resultant increase in mucin secretion (Miller 
& Nawa, 1979). The increased amount of mucus is thought to 
prevent the worms from taking up their normal position between 
the villi (Miller, Huntley & Wallace, 1981). This is known as 
immune exclusion. Perhaps also, specific anti-worm antibody 
which has leaked into the intestine acts directly on the worms 
(Barth, Jarrett & Urquhart, 1966).
Turning to parasites which undergo tissue migration, one of 
the common features is eosinophilia (Wakelin, 1984). Recently in 
this respect an important advance was the finding of Butterworth, 
Sturrock, Houba & Rees (1974) that peripheral blood leucocytes 
could kill schistosomula of Schistosoma mansoni in vitro. The 
same group (Butterworth, Sturrock, Houba, Mahmoud, Sher, & Rees, 
1975) found that the best mediator of schistosomula damage was 
the eosinophil. Since then, much has been written on the subject 
including several reviews (Kay 1979, Butterworth, Taylor, Veith, 
Vadas, Dessein, Sturrock & Wells 1982).
Anwar & Kay (1 977a) discovered that eosinophils had 
receptors for the Fc portion of IgG and for the 0 3 b fraction of 
complement. Butterworth, Remold, Houba, David, Franks, David & 
Sturrock (1977) showed that eosinophils would mediate 
schistosomula killing in the presence of antibody alone. Anwar, 
Smithers & Kay (1979) finally showed that while eosinophil 
mediated killing could be achieved with antibody alone or 
complement alone it was greatly enhanced when antibody and
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complement were both present.
Anwar and Kay (1977b) had previously shown that the mast­
cell derived products Eosinophil Chemotactic Factor of 
Anaphylaxis (ECF-A) and histamine increased the number of 
complement receptors on the eosinophil. Gathering all this 
together Kay (1979) was able to propose the following theory.
He suggests that when the cercaria of a schistosome enters 
the skin of a previously exposed animal the schistosomulum 
becomes coated with IgG and also activates the alternative 
pathway of complement. Mast cells in the skin adhere to the 
schistosomulum by means of specific IgE and complement receptors. 
These mast cells degranulate as in a type I hypersensitivity 
reaction releasing ECF-A and histamine. Eosinophils are 
attracted to the site and display an increased number of 
complement receptors due to the enhancement by the mast cell 
products. These eosinophils then adhere to the schistosomulum by 
their complement and IgG receptors. They are now in a position 
to damage the schistosomulum by degranulating on to its tegument.
Eosinophil granules have been shown to contain peroxidase 
(McLaren, MacKenzie and Ramalho-Pinto 1977), a major basic 
protein (MBP) (Gleich, Loegering & Maldonado, 1973) and 
eosinophil cationic protein (ECP) (Olsson and Venge 1974). 
Studies using electron microscopy have shown that schistosomulum 
damage is indeed associated with eosinophil degranulation 
(McLaren 1980). These ultrastructural studies show that holes 
appear in the surface tissues of the parasites at the site of 
degranulation. The damage is further increased by the active 
movement of the eosinophil into the hole forcing apart the
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already damaged tissues.
While many papers concerning immunity to Dictyocaulus have 
been written (especially in the early '60s) few authors have been 
willing to speculate on the mechanisms involved in this immune 
response. As this parasite has a lumen-dwelling adult stage 
(albeit lung rather than intestine) it may be that mechanisms 
similar to those involved in protection against Nippostrongylus 
are operating. However, it also has a tissue migrating phase 
which may make it vulnerable to cell-mediated killing such as is 
thought to occur in infections with Schistosoma mansoni.
The serological response to primary and secondary infections 
has been followed using complement fixation (CF) tests (Jarrett, 
Jennings, McIntyre, Mulligan & Urquhart 1955a; Weber 1958; 
Jarrett, Jennings, McIntyre, Mulligan, Thomas and Urquhart 
1959b). Jarrett and his co-workers reported that complement 
fixing antibodies appeared in the serum around day 30-35 of a 
primary infection and rose to a peak around day 80 by which time 
the infection had been eliminated. In response to secondary and 
subsequent infections the peak level was higher and attained 
earlier, a situation typical of a secondary antibody response. 
Weber (1958), however, found no such secondary response. He 
obtained peak titres at day 18 in both primary and secondary 
infections and saw no significant increase in the levels of the 
peak titres.
Jarrett et al. (1955a) also showed that a globulin fraction 
of serum isolated from immune calves at the peak of their 
complement fixing antibody response could be used to protect
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naive calves against challenge. Rubin & Weber (1955) also 
carried out serum transfer experiments. While both groups showed 
that protective substances had been transferred, the volumes of 
serum used were quite large. Thus, Jarrett et al. used 1,500 ml. 
of globulin fraction (equivalent to about 4.5 litres of whole 
serum) while Rubin & Weber injected approximately 750-800 ml. of 
whole serum.
Jarrett et al. (1955a) stated that "in parasitic bronchitis 
there are humoral antibodies which are detectable and measurable 
by a complement fixation test, and the serum containing these 
antibodies confers a considerable degree of protection against a 
single challenging infection of infective larvae of 
Dictyocaulus viviparus". Michel & Cornwell (1959) interpreted 
this as an assumption that the antibodies which were detected by 
the CF test and the antibodies which transferred protection were 
homologous and carried out a series of studies on the CF antibody 
response to lungworm infection (Michel & Cornwell, 1959; Cornwell 
& Michel, 1960; Cornwell, 1960a; Cornwell, 1960b). From these 
they finally concluded that there was little correlation between 
CF titres and protective immunity.
Attention then switched to the possibility of actively 
immunising calves using dead antigens. Jarrett, Jennings, 
McIntyre, Mulligan & Urquhart (1960b) performed experiments using 
an adjuvanted adult worm homogenate administered intramuscularly. 
While a reduction in worm burdens was noted in some of the 
experimental groups after challenge, it was concluded that 
protection was not great enough to be of any practical use. 
However, although little useful immunity was achieved the
34
vaccination produced an exaggerated response to the presence of 
adult parasites in the lung. This response was associated with 
eosinophil infiltration into the lobules and giant-cell 
phagocytosis of the worm material. This caused greater damage 
to the lung tissue than would normally be seen in a primary 
infection.
Wade, Swanson & Fox (1961) carried out active immunisation 
experiments on rabbits and guinea-pigs. They quote a 50% 
reduction in worm burdens in guinea-pigs given larval antigen 
over adjuvant only challenge controls; however, the significance 
of the paper is cast into doubt by a 58% worm burden reduction in 
a group vaccinated with saline alone. In a second paper (Wade, 
Swanson, Fox, Simpson & Malewitz, 1962) they give the results of 
vaccination experiments, conducted on calves, using a mixed 
larval and adult lungworm antigen. In this work eight month old 
calves showed a 80% reduction in worm burden following challenge. 
However, the significance here could also be questioned on the 
grounds that this reduction was from a 1 % establishment in the 
controls to 0.2% in the vaccinates. One percent establishment in 
a control infection is extremely low and highlights a poor and 
possibly variable infectivity.
In 1957 Jarrett et al. (1957a) announced that experiments 
using x-irradiated lungworm larvae as a vaccine had shown 
sufficient promise to have reached the stage of a field trial. 
More full details were released in the following years (Jarrett, 
Jennings, Martin, McIntyre, Mulligan, Sharp & Urquhart 1958a; 
Jarrett, Jennings, McIntyre, Mulligan & Urquhart 1958b; Jarrett,
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Jennings, McIntyre, Mulligan, Sharp & Urquhart 1959a; Sharp 1959; 
Jarrett, Jennings, McIntyre, Mulligan & Urquhart 1960c; Jarrett, 
Jennings, McIntyre, Mulligan & Sharp, 1961.
The discovery was based on the theory that the mesenteric 
lymph nodes were the site where larvae were killed in the immune 
animal. If lungworm larvae could be attenuated in such a way 
that they would remain infective yet die in the mesenteric lymph 
nodes then it was thought that immunity might be achieved without 
causing serious lung damage or clinical disease. Such a means of 
attenuation was found in irradiation with x-rays.
It was shown (Jarrett et al. 1 960a) that a suitable degree 
of attenuation was produced at 40,000 roentgens. Oral 
administration of a single dose of 4,000 third-stage larvae 
irradiated at this level gave 98.5% protection against subsequent 
challenge. Jarrett et al. (1958a) conducted an experiment to 
assess the protection afforded by this form of vaccination under 
field conditions. In this trial the vaccine dose was reduced to 
1,000 irradiated larvae. Following a very high pasture 
challenge, 3 out of 15 vaccinates died compared with 10 out of 12 
controls. While this trial showed that a high level of 
protection could be given by a single dose of vaccine it was 
thought that two doses might provide a higher degree of immunity. 
Thus Jarrett et al. (1959a) performed an experiment in which 
calves were vaccinated with 1000 irradiated larvae on Day 0 as 
before and then given a second dose of vaccine on Day 42. The 
three doubly vaccinated groups received 4,000, 2,000 or 1,000 
irradiated larvae respectively as the second dose. All were 
challenged with a single dose of 10,000 normal larvae on Day 93.
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In none of the double vaccinates did the challenge reach patency 
and no adult worms were found at necropsy. In contrast, calves 
given a single dose of 1,000 irradiated larvae on Day 0 and 
challenged as above on Day 93 produced patent infections and a 
mean of 820 adult worms was found at post-mortem. No appreciable 
difference was observed between the different doubly vaccinated 
groups.
Again, a small-scale field trial was carried out (Jarrett et 
al., 1961) this time using the double vaccination procedure with 
both doses set at 1,000 irradiated larvae. The interval between 
doses was shortened to 30 days and the vaccinated calves were 
turned on to contaminated pasture along with challenge controls 
20 days after the second vaccine dose. In none of the vaccinated 
calves could any mature lungworms be found at post-mortem 
examination 10 weeks later. In contrast, one of the control 
calves died of pre-patent husk and a mean of about 400 mature 
worms was found in the survivors.
A practical method had thus been devised whereby calves 
could be protected against clinical lungworm disease by the oral 
administration of two doses of 1 , 0 0 0  third-stage Dictyocaulus 
viviparus larvae irradiated by x-rays at 40,000 roentgens.
A commercial form of this vaccine was developed and launched 
by Allen & Hanburys on the 25th. February 1 959 as "Dictol". It 
was widely hailed as the world's "first" commercial helminth 
vaccine as it was anticipated that many more such vaccines would 
follow. Poynter et al. (1960) reported experiments in calves and 
guinea-pigs conducted during the commercial development of the
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vaccine. This group concluded that, contrary to the belief of 
Jarrett et al., there was no evidence to suggest that irradiated 
larvae died in the mesenteric lymph nodes. Nor did they find 
that this was the site where larvae were killed in the immune 
animal. Furthermore, they showed that, in calves as well as 
guinea-pigs, at least some larvae from an initial infecting dose 
were in the lungs by 36 hours i.e. some 5 days before Jarrett et 
al. had found their arrival in this organ and possibly indicative 
of a direct haematogenous route from the intestine to the lung.
However, Jarrett & Sharp (1963) remained unconvinced. In 
serial kills they could not find larvae in the lungs of calves 
before day 7. Even then, far fewer larvae were recovered from 
the lungs from a single dose of 1 , 0 0 0  irradiated larvae than from 
a similar dose of normal larvae. They argued that the larvae 
which Poynter recovered from the lungs had followed some aberrant 
migration and were only observed because of the higher challenge 
dose used. Also, considering the total numbers of larvae 
recovered from the lungs and lymph nodes, this still left the 
majority of larvae unaccounted for. Jarrett & Sharp considered 
that while it was possible that irradiated larvae were quickly 
expelled from the lung by ciliary/mucus movement, no histological 
evidence of their migration through the lung could be found. In 
contrast dead larvae could be found in the mesenteric lymph nodes 
although no figures were given for the numbers of such larvae. 
They concluded that the exact fate of irradiated larvae was 
uncertain, but reiterated their belief in the lymph node theory 
and also postulated a role for the bowel wall in preventing 
establishment in the hyperimmune animal.
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Cornwell & Jones (1970a, 1970b, 1970c & 1971) used triethyl 
melamine to attenuate infective Dictyocaulus larvae and found the 
vaccine thus obtained to be as protective as irradiation- 
attenuated vaccine.
Others, (Bonazzi, Grimshaw, Bairden, Armour & Gettinby,
1983) have used gamma-irradiation instead of x-irradiation. The
principal benefit of using gamma-rays from a Cobalt 60 source is
the short time taken to attenuate the larvae. 40Krads can be
achieved in less than an hour from a ^Co source whereas the
same irradiation dose takes 6 hours 40 minutes on the production
line at Ware. However, uncertainty surrounds the comparative
attenuation achieved by these two sources of irradiation. Kassai,
Fitzpatrick & Mulligan (1966) calculated a "Relative Biological
Effect" (RBE) based on the percentage establishment of
Nippostrongylus brasiliensis in the rat. They found that ^Co
gamma-irradiation had only 70% of the RBE of x-irradiation at the
same dose. It must be stressed, however, that this figure is
based on the number of worms reaching adulthood in the rat's
intestine and may therefore have a limited relevance to lungworm
vaccination where the important factor is probably the
invasiveness of the larvae and not their ability to become adult.
Indeed, Bonazzi et al (1983) achieved effective vaccination
against D.viviparus using 40Kr from ^Co. where Kassai's figures
would suggest 57 Kr as being the required dose. Other workers
(Rodriguez, personal communication) oblivious of Kassai's RBE
60value have used 40Kr from a ° Co source successfully.
Cornwell (1960a, 1960b) followed the complement-fixing
39
antibody response of calves during the vaccination period. He 
found that the first dose of vaccine produced a low level of CF 
antibody, at least as detected by a test using adult worm 
antigen. The second dose elicited a variable rise in titre 
although by the time the calves were ready to be put out to grass 
four weeks later, none of the titres could be described as high. 
It was suggested that the CF titre was in response to adult worm 
antigens and that the variable titre reflected the numbers of 
irradiated larvae which reached the lungs. When exposed to 
challenge (Cornwell, 1960b) those calves which had been 
vaccinated showed an immediate rise in CF titres whereas 
unvaccinated calves had a delay of 5 - 6 weeks before the titre 
began to rise. Even calves in which no detectable response to 
vaccination had occurred showed an early response to challenge. 
It was therefore clear that CF titres could not be used to 
estimate the immune status of an animal before challenge.
Cornwell (1962b), MacKenzie & Michel (1964) and Downey 
(1965) have examined the eosinophil response in cattle following 
challenge, vaccination and immune challenge.
Challenged naive calves show two peaks of circulating 
eosinophil numbers. The first response was at Days 9-15 and the 
second around day 40. Cornwell (1962b) found that in a primary 
infection the second eosinophil rise was the higher. After 
reinfection the response was quicker and this time the first 
response was the greater. Administration of irradiated larvae 
produced only the first rise in eosinophils and it was therefore 
suggested that the double peak in response to normal primary 
infection corresponded to an initial response to invading larvae
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followed by a response to aspirated eggs once the worms reached 
patency. It follows then that irradiated larvae would only 
elicit the first response, i.e. that to the invading larvae.
An eosinophil response was shown in-vitro by Knapp & Oakley 
(1981). Third stage D.viviparus larvae incubated in the presence 
of whole blood were seen to become coated with cells, especially 
eosinophils and to a lesser extent neutrophils.
Wilson (1966) investigated further the role and nature of 
circulating antibodies to lungworm infection using the guinea-pig 
as a model. He found that protection was associated with 
gamma-] -globulin and fast-moving gamma2 -globulin and that these 
globulin fractions also showed anaphylactic activity. These 
antibodies are first detected in a primary infection during the 
elimination period at days 8-13 post infection. Guinea-pigs 
artificially immunised with Freund's adjuvanted adult worm 
homogenate produced anaphylactic gamma-] and gamma2  globulins but 
failed to protect against subsequent challenge.
It would appear to be possible that the strong immunity 
mounted in cattle against infection with Dictyocaulus viviparus 
is based on an eosinophil-mediated, antibody-dependant cellular 
cytotoxicity reaction. The great amount of eosinophil infiltrate 
and the lymphoid nodules found in the lungs of challenged immune 
calves would suggest that this killing is effected against the 
or in the lungs. Using man and asthma as a parameter it seems 
that the lung is well suited to mounting anaphylactic responses 
against airborn antigens. It is possible then to hypothesise 
that the immune response involves the recognition of lungworm
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antigens by mast cells carrying specific anti-larval IgE. These 
would degranulate releasing, amongst other factors, ECF-A. 
Eosinophils would therefore be attracted to the site and could 
effect larval killing possibly by binding to complement on the 
surface of the parasite.
As mentioned earlier, the basic theory behind "Dictol" 
presumed that the mesenteric lymph nodes were the important site 
of larval killing and therefore for a vaccine to be effective the 
majority of the attenuated larvae would have to die in these 
tissues. In contrast, if the effector mechanisms are active in 
the lung, then vaccination with attenuated larvae by some 
parenteral route might prove possible. However, to be 
commercially acceptable, a parenterally administered vaccine 
would have to be sterile. The bulk of this thesis is therefore 
concerned with these two concepts, producing a sterile larval 
suspension and exploring the possibilities of parenteral 
vaccination.
In this context the work of Miller (reviewed in Miller 1971, 
Advances in Parasitology 9_ and Miller 1 978, Advances in 
Parasitology 16) is of note. This work centred around the 
problems of producing an irradiated vaccine against disease 
caused by Ancylostoma caninum in the dog. Eggs of Ancylostoma 
were washed in hypochlorite prior to hatching and the larvae were 
kept in sterile culture and fed on killed E.coli. Once 
infective, the larvae were irradiated and the resultant vaccine 
was administered subcutaneously. In the case of Ancylostoma, 
subcutaneous administration was the natural route of infection 
and therefore the obvious route for vaccination. Also, the fact 
that eggs are produced by A.caninum may perhaps be considered to 
have made the process of sterilisation less difficult compared 
with the problems of sterilising D.viviparus larvae passed in the 
faeces.
Chapter Two.
Materials and Methods.
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Animals.
a. Calves.
In all experiments, male, 10 week old, weaned Ayrshire or 
Friesian cross calves weighing 80- 110 kg. were used. These were 
obtained from local sources where calves were known to be reared
under conditions in which infection with helminth larvae was
improbable. At the Parasitology Department the calves were
bedded on clean straw which was replaced every second day. They
were fed 1kg. of concentrate and 3kg. of hay daily. Water was
available ad libitum.
b. Guinea-pigs.
Duncan-Hartley guinea-pigs were obtained from the Royal 
Hospital for Sick Children, Yorkhill, Glasgow. These were housed 
in plastic cages with wire mesh tops. They were fed on pelleted 
diet plus hay, lettuce leaves and water ad libitum. The animal 
house temperature was maintained at approximately 22°C.
Respiratory Rates.
Respiratory rates were estimated by counting the number of 
respirations in 15 seconds and multiplying that figure to give 
the number per minute.
Faecal Examinations.
Faecal samples were collected from the rectum and examined 
for helminth eggs or larvae by a modified McMaster flotation 
technique (Gordon & Whitlock, 1939) or a modified Baermann method 
(Henrikson, 1965).
a. Modified McMaster Method
Three grammes of fresh faeces was homogenised with 42 ml. of 
water and the resultant suspension passed through a coarse mesh
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sieve of aperture size 250 microns (Endecotts Test Sieves Ltd., 
Morden, London.). After thorough mixing of the filtrate, 15 ml. 
was withdrawn into a flat-bottomed centrifuge tube (capacity 15 
ml.) and centrifuged at 2 0 0 0  revolutions per minute for 2  
minutes. The supernatant was then discarded and the remaining 
faecal pellet broken up by rotary agitation (Whirlimixer, Griffin 
& George, Wembley, Middlesex). The tube was then filled to its 
former level with saturated salt solution and after inverting 6  
times a volume of the suspension, sufficient to fill both 
chambers, was quickly transferred to a two-chambered McMaster 
slide (Gelman Hawksley, Harrowden, Northampton.). The number of 
larvae under the total etched area of the slide was counted and 
the result multiplied by 50 to give the number of eggs or larvae 
per gramme of faeces,
b. Modified Baermann
Ten grammes of faeces was placed in gauze and suspended in 
warm saline in a plastic 250 ml. urine-glass for six hours, after 
which time both faeces and gauze were discarded. The suspension 
was allowed to sediment for three hours at 4°C and the 
supernatant removed to give a final volume of 10 ml.. This was 
well mixed and the larvae present in a 1 ml. aliquot was counted 
and expressed as the number of larvae per gramme faeces.
Infective larvae.
Infective third stage larvae of Dictyocaulus viviparus were 
provided by Glaxovet, Ware, England. Larval inocula were 
prepared by counting the number of larvae present in 40 x 0.025 
ml. aliquots. To facilitate counting the larval dilution was so
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arranged that the number of L3 per 0.025 ml. aliquot was 
approximately 30. Once the number of L3 present in 1 ml. was 
known, the volume needed to provide the required inoculum was 
pipetted out and made up to the desired volume for infecting the 
animals. Throughout the whole counting procedure emphasis was 
placed on regular mixing of the larval suspension to prevent 
clumping.
Infection process.
a) Calves.
The required number of larvae were counted as above and 
diluted with distilled water to a final volume of 20 ml.. The 
dose was made up in 30 ml., glass, narrow-mouthed bottles with 
metal caps (used, washed Dictol bottles). Calves were held 
firmly and their mouths opened using the left hand, leaving the 
right hand free to mix the contents of the bottle and pour it 
down the animal's throat. Bottles were further washed out with 
distilled water and the washings poured into the animal's mouth 
as above.
b) Guinea-pigs.
The necessary number of larvae, usually at a concentration 
of c1200 L3 /111I. was put into conical centrifuge tubes and allowed 
to sediment at 4°C for 4 hours. Excess supernatant was then 
removed to give a final volume of 1 ml.. Oral infection was by 
use of a shortened intravenous cannula (Red Luer, 5 FG O/D 1.65 
mm., Portex Ltd., Hythe, Kent.) connected to a plastic 2ml. 
syringe. Guinea-pigs were lightly anaesthetised using 
trichloroethylene (Trilene, BDH Chemicals Ltd., Poole, Dorset.)
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and the cannula gently introduced into the animal's oesophagus. 
Sub-cutaneous inoculation was performed using a 2 ml. syringe and 
a 20 gauge, 1 inch needle (Becton-Dickinson, Wembley, England). A 
fold of skin in the guinea-pig's neck was chosen as the site of 
inoculation.
Exsheathing process.
Where exsheathed larvae were used the exsheathment was 
achieved using 5% Milton's Fluid (Milton 2, Richardson-Vicks 
Ltd., England) equivalent to 0.001% w/v sodium hypochlorite. A 
known number of larvae was suspended in this solution for 15 
minutes then centrifuged lightly (500 rpm for 5 minutes) 3 times, 
replacing the supernatant with distilled water each time.
Vaccine.
"Dictol" oral lungworm vaccine was provided by Glaxovet, 
Ware, England. This was pooled and used as a stock solution of 
40 Kr, x-irradiated larvae.
In experiment 4 in Chapter 6 , normal infective larvae were 
irradiated in the chamber of a Cobalt 60 source (Nuclear 
Engineering, Berkshire, England). The output of the irradiation 
source at the time of preparation was 695 rads/min. Therefore to 
achieve the required dosage of 70 kr, the larvae were left in the 
chamber for 1 0 1 minutes.
Irradiated larvae were counted as before and the required 
number suspended in 2ml. distilled water for injection.
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Vaccination.
Doses of vaccine were administered by one of three routes:
1) Orally.
As described in the "Dictol" data sheets.
2 ) Intra-peritoneally.
Intra-peritoneal injections were performed using a 5 ml. 
sterile plastic syringe and 18 gauge 1.5 inch needles (Becton- 
Dickinson, Wembley, England). The site of injection was chosen 
as the lower portion of the iliac triangle of the calf's right 
flank.
3) Sub-cutaneously.
Sub-cutaneous injections were carried out using the same 
type of syringes as above and 20 gauge, 1 inch needles. The site 
chosen was a fold of skin on the right shoulder.
Post-mortem technique,
a) Calves.
Calves were stunned by a captive-bolt pistol and immediately 
pithed and bled out. The lungs were then removed together with 
the trachea, oesophagus, heart and pericardial sac.
The exterior of the lungs was washed in running water and 
the lungs laid out on plastic trays. Any consolidation present 
was drawn on to lung "maps" for later estimation of the lesion 
scores. The bronchi were then cut open using round-ended scissors 
and lungworms removed to normal saline with forceps. Worms were 
stored in saline at 4°C and counted within a few days of 
collection. Lesion scores were calculated by assigning each of 
the lung maps described above a value between 0 and 5 where 0
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represented no consolidation and 5, 50% consolidation,
b) Guinea-pigs.
Guinea-pigs were killed by deep anaesthesia in Trilene, 
followed by dislocation of the neck. The chest was opened with 
fine scissors and the lungs and heart removed. The lungs were 
then separated from the heart, chopped finely and suspended in 
gauze in warm saline overnight. After incubation, the lung 
tissue and gauze were discarded and the saline centrifuged to 
concentrate the lungworm larvae. The total number of larvae 
collected was then counted under a dissecting microscope.
Larval Viability.
The viability of Dictyocaulus infective larvae was estimated 
microscopically. Aliquots of larvae were taken from well-mixed 
samples, placed on clean, glass microscope slides and examined 
under a dissecting microscope. Larvae were considered to be 
alive if they were motile or capable of maintaining a tightly 
coiled posture. Results were expressed as the number alive as a 
percentage of the total. Normally a minimum of 100 larvae was 
counted.
Bottles Testing.
The number of larvae per ml. of vaccine in the bottles 
examined in Chapter Four were counted in the following way : 
Bottles were inverted seven times to ensure adequate mixing, the 
caps were removed and the contents were emptied into a clean 
100 ml. glass beaker. The total volume was poured from one 
beaker to another six times to ensure thorough mixing prior to 
the removal of sufficient fluid to fill the chamber of an eelworm
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counting slide (Gelman-Hawksley, England). The number of larvae 
in the etched area was counted. This corresponded to 1ml. of 
vaccine. Five such aliquots were counted per bottle.
Sterilisation.
Bottles of nutrient agar or water, screw-capped glass tubes 
and cellulose acetate filters were sterilised in an automatic 
pressure cooker (Tower, England). Pressure was raised to 1.05 
kg. per cnr (15 lbs./in ) and maintained for 15 minutes.
Filtration apparatus was sterilised in a bench autoclave 
(Denley, Billingshurst, England) again at 1.05 kg/cm for 15 min.
Culture Media.
Nutrient agar (Oxoid) was made up following the 
manufacturer's instructions. Batches of agar were dispensed into 
30 ml. glass universals and sterilised as above. These were 
stored at 4°C until use. Prior to use the agar was melted in an 
instrument steriliser and poured on to sterile plastic petri 
dishes (Sterilin, Teddington, Middlesex, England). In certain 
instances this was enriched with 1 0 % bovine blood freshly 
collected by sterile means.
Incubation.
Agar plates were incubated either at 37°C or room 
temperature under aerobic or anaerobic conditions. Aerobic 
conditions were achieved simply by placing the agar plates in a 
37°C incubator or by leaving them in a plastic box on the bench. 
Anaerobic conditions were maintained using anaerobic jars which 
were gassed using Gaspak disposable hydrogen and carbon dioxide
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generator envelopes (Becton-Dickinson, Wembley, England). 
Anaerobic jars were placed in a 37°C incubator or left on the 
bench.
Examination of agar plates.
After the incubation period had elapsed the plates were 
examined by eye and the number of discrete colonies counted. The 
colonies were presumed to have arisen from individual bacteria 
and their number was calculated back to give the bacterial 
concentration in the original preparation.
Filtration.
For determination of bacteriological sterility, preparations 
were passed through 0.22 urn. pore size, 47 mm diameter cellulose 
acetate filters (Millipore, Germany) in a standard 
bacteriological filtration apparatus.
Virology.
The materials and methods used in the virus experiments are 
outlined in the appendix to Chapter Seven.
Chapter Three.
The preparation of a bacteriologically sterile 
irradiated larval vaccine.
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The larval suspension used by Glaxo Operations Ltd. at Ware 
(Herts.) in the commercial production of Dictol, is isolated from 
faecal culture by a process of migration, sieving and washing. 
It could therefore be expected that Dictol would contain 
contaminating enteric bacteria. If adequate precautions were not 
taken, pathogens present in the culture calves could very quickly 
be spread via Dictol to calves all over Britain and indeed to 
many European countries. Obviously precautions such as screening 
the culture calves for the presence of Salmonella spp. are taken 
to prevent this. However, at present these are restricted to 
scrupulous cleanliness and prophylactic measures at Bury Green 
Farm and Lady Hayes Farm. While up to now these safety measures 
have proved adequate, and it could be argued that an oral vaccine 
does not need to be sterile, the time could arise when a sterile 
Dictol would be necessary in order to pass more stringent 
licencing requirements in the future or to sell Dictol in 
countries that are unwilling to import the current non-sterile 
product. It would also be of prime importance if a live 
injectable vaccine was to prove possible. The need for sterility 
in an injectable system is borne out by the perhaps apocryphal 
story related by Nelson (1984), where in the early days of the 
vaccine, one farmer complained to Allen and Hanbury's of the 
abscesses which formed when he injected his calves with Dictol.
Most of the usual methods of rendering substances sterile 
are not applicable to Dictol. Obviously heat treatment or 
autoclaving would kill the larvae. Filtration is equally 
impossible. Irradiating the vaccine with gamma rays would
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possibly require up to four megarads - one hundred times the dose 
which is used to attenuate Dictol. The inclusion of an 
antibiotic in the larval suspension would be feasible but is 
undesirable on the grounds that it might select for antibiotic 
resistant strains. The only method remaining is the use of 
chemical disinfectants. Even here the choice of compound is 
limited. The use of disinfectants which incorporate heavy metals 
is considered undesirable. Also substances which are likely to 
exsheath the larvae have to be avoided. The ideal chemical (or 
commercial disinfectant) would have a wide spectrum of activity 
at very low concentrations, have no effect on the larvae, be 
easily incorporated into the production process and be available 
cheaply.
Determination of Oontainination level.
A previously unopened bottle of normal D.viviparus third 
stage larvae from Ware (23,400 larvae/ml.) was examined for the 
presence of bacteria. Two 0.5ml. samples were removed from the 
bottle and diluted with sterile water to give final dilutions of 
1/20, 1/200 and 1/2000. 4.5ml. samples of these dilutions were 
passed through 47mm. cellulose acetate filters with a pore size 
of 22um.. The filters were then incubated overnight at 37°C on 
nutrient agar (N.A.) and blood agar (B.A.) under aerobic and 
anaerobic conditions.
The results of the incubation in aerobic conditions are 
shown in Table 1. Only minimal growth was observed on the plates 
incubated in anaerobic conditions.
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Table 1.
The number of bacterial colonies observed after aerobic 
incubation of diluted larval suspensions.
Dilution : 1/20 1 / 2 0 0 1 / 2 0 0 0
Blood agar tmtc 2 1 0
Nutrient agar tmtc 1 2 2 2
tmtc = too many to count.
From the 1/200 N.A. plate the contamination level was
•3
estimated to be 5.4 x 10 bacteria per ml. of the larval 
suspension.
The above procedure was repeated using an unopened bottle of 
Dictol. 20ml. was diluted to give 18ml. each of a 100%, 10% and 
1 % concentration. A sterile water control was also filtered. 
All were incubated on B.A. at 37°C for 18 hours and the results 
are shown in Table 2.
Table 2.
The degree of bacterial contamination of Dictol. 
Dictol Dilution Number of colonies
Undiluted tmtc
10% Dictol 1160
1% Dictol 170
Sterile water 0
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The bacterial level in the Dictol bottle therefore was 
between 644 and 944 bacteria/ml. This is equivalent to between 
15,500 and 22,700 bacteria per dose of Dictol.
Identification of Contaminants.
Selected colonies from the first filtration experiment 
outlined above were replated on B.A. These were sent to Dr 
Birkbeck, Microbiology Department, Glasgow University, for 
identification. This was done by grams stain and API strips for 
the identification of enteric bacteria. Of 9 samples examined, 3 
appeared to be E.coli, 3 Pseudomonas spp. and 3 were 
unidentifiable. One of the E.coli isolates was maintained in 
culture for use in the subsequent bactericidal tests.
Disinfectant Screening.
A number of potentially bactericidal compounds were added to 
larval suspensions to determine their toxicity to Dictyocaulus 
L3 . The larvae were then examined microscopically for viability. 
A 10% formaldehyde (HCHO) solution killed the larvae within 30 
minutes as did 1% HCHO and 1% Savlon. 0.8% Milton's Fluid 
exsheathed the larvae. The larvae survived 30 minutes in 1 % 
Pevidene and 1% Jeyes Ibocol. They also survived 90 minutes in 
1 /1 0 N HC1 at pH2 and 2% I^C^Oy.
Doubling dilutions of Cetavlon, Ibocol and Pevidene were 
made up ranging from 25% down to 0.8%. All dilutions of Cetavlon 
and Ibocol killed the larvae by 2 hours. Larvae survived slightly 
better in Pevidene in that a few larvae survived 3 hours in the
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25% solution but even at the lower dilutions dead larvae were 
present.
37 ppm HCHO was tried next and larvae survived this for more 
than 2 hours. A 37ppm solution of HCHO was inoculated with 
bacteria, incubated for an hour and the fluid plated on to agar. 
Heavy growth was apparent on this and on a water control. This 
procedure was repeated with concentrations of HCHO ranging from 
370ppm to 25ppm. Moderately heavy growth was found from all 
dilutions becoming heavier in the lower concentrations of HCHO.
A suspension of bacteria was made such that it had an
g
optical density (O.D.) at 600nm. of 0.92 (approximately 10 
bacteria/ml.). This was diluted 1:10 with sterile water then 
0.1ml was added to 9.9ml. of the following solutions : 370ppm 
HCHO; 37ppm HCHO; 1 % Pevidene; 2% I^G^Oy and sterile water. 
After 1 hour at room temperature these were diluted 1:100 and 
0.1ml was plated on to B.A. The results are shown in Table 3.
Table 3
The bactericidal activity of some disinfectants
Disinfectant Number of colonies
370ppm HCHO 4
37ppm HCHO tmtc
1% Pevidene 1
2% K2CT2 Oy 0
H2 O control 38
This above test was repeated with dilutions of I^C^Oy and 
the results are shown in Table 4.
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Table 4.
The bactericidal activity of dichromate dilutions.
Disinfectant dilution Number of colonies
2% I 1
2
0.5% ii 0
0.2% ii 1
H2 O control 554
The percentage kill therefore was between 99.6% and 100% for 
all dilutions tested and at this point Potassium dichromate 
appeared to be the best solution examined.
Panacide.
At this stage a disinfectant marketed by BDH Chemicals 
(Poole, Dorset) called Panacide was investigated. This product 
claimed to be a good bactericide, algicide and fungicide at 
concentrations as low as 0.006% w/v of active ingredient. 
Panacide is the trade name for 5,5,-Dichloro-2,2'- 
dihydroxydiphenylmethane which has the common name dichlorophen. 
Panacide is approved by the M.A.F.F. for animal husbandry and the 
storage of wheat, potatoes and bananas. It is also permitted by 
the E.E.C. as a preservative for cosmetics. The pharmaceutical 
grade of dichlorophen is used as a Taeniacide in animals and man. 
The product investigated was a 40% w/w solution of the technical
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grade monosodium salt of dichlorophen. All the subsequent tests 
were performed using dilutions of this stock solution and quoted 
as percentage w/v solutions of sodium dichlorophen.
Dichlorophen Results.
Dichlorophen was tested in a similar manner to that used for 
the previous compounds under investigation. Larvae were 
suspended in doubling dilutions of dichlorophen from 1 0 % w/v 
solution to 0.004% w/v. After 3 hours no harmful effects could 
be seen below a 1.25% w/v solution.
Again a bacterial culture was made at an O.D. of 0.90. 'This 
was added in the ratio of 1 : 1 0 0 0  to various dilutions of 
dichlorophen. After one hour incubation this was diluted a 
further 1:100 and 0.1ml. plated on to agar. The results are 
shown in Table 5.
Table 5
The bactericidal activity of dichlorophen dilutions.
dichlorophen dilution No. of Colonies
0.4% 0
0.24% 0
0.024% 0
0.0024% 0
sterile water 780
This represents 100% bactericidal activity at all the 
dilutions tested.
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Following these promising results from dichlorophen a 
further viability test was performed.
A series of sterile stoppered tubes was set up each 
containing c730 L3 in 1ml.. To this was added 3ml. dichlorophen 
(to a final dilution of 0.0024%) or 3ml. distilled water. The 
dichlorophen was left in the tubes for 1 hour then replaced with 
two changes of sterile water. The tubes were stoppered and 
stored at 4°C. On selected days thereafter, percentage viability 
counts were performed by microscope. These are shown in Table 6 .
Table 6.
The percentage long-term viability of larvae washed in 
0.0024% w/v dichlorophen or in distilled water.
Day 0 7 15 2 2 31 55
dichlorophen 98.8 98.3 99.1 98.4 98.2 96.0
Control 99.1 98.7 98.4 95.7 98.3 97.1
This shows that dichlorophen washed larvae remained as 
viable as the controls over a 55 day period (13 days beyond the 
42 day shelf-life for which Dictol is licenced).
At day 1 5 in the above trial 0.1ml. from two control tubes 
and two dichlorophen washed tubes was plated on to nutrient agar. 
The results are shown in Table 7.
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Table 7.
A comparison of numbers of bacteria in dichlorophen-washed or 
water-washed larval suspensions after 15 days storage.
Treatment Number of colonies
dichlorophen wash 0 0
water wash 75 90
At day 23, 20ml. of a 1/10 dilution from control and 
dichlorophen treated tubes was filtered and the filters incubated 
on nutrient agar. The results are shown in Table 8 .
Table 8.
A comparison of numbers of bacteria in dichlorophen-washed or 
water-washed larval suspensions after 23 days storage.
Treatment Number of colonies
dichlorophen wash 0
water wash tmtc
Infectivity.
While the viability as determined microscopically may have 
remained high in the samples of washed larvae the relevance of 
this to actual infectivity is questionable. An experiment was 
therefore performed to infect calves with dichlorophen washed 
larvae. Six doses of 5,000 larvae were made up. Two were made to
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20ml. with distilled water and used as controls. The remaining 
four were made to 20ml. as 0.0024% w/v dichlorophen. These were 
left for 90 minutes then the supernatant was replaced with 
sterile water 3 times - allowing 30 minutes for sedimentation 
between each wash. All six doses were stored at 4°C until used. 
The day the doses were made up was taken as day 0. Three calves 
were infected on day 14 and three on day 42, two dichlorophen 
treated and one control at each occasion. Each calf was killed 
28 days after it was infected and the total number of worms 
present in the lungs was counted. The results are shown in 
Table 9.
Table 9.
Post-mortem worm burdens of calves infected with dichlorophen 
washed or unwashed larvae after 14 or 42 days storage.
day 14 infection day 42 infection
dichlorophen wash 1090 495
dichlorophen wash 1405 840
Control 1780 645
All calves displayed clinical symptoms of husk and at 
necropsy showed typical lungworm lesions.
Larval Filtration.
A final filtration experiment was performed to investigate 
the internal cleanliness of dichlorophen washed larvae. It was
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thought possible that while the exterior of the larval sheath may 
have been freed from bacteria the inside of the sheath may still 
be able to harbour pathogens.
Larvae were suspended at 10,000 L3 /111I. and washed in 
dichlorophen followed by sterile water as before. Controls were 
set up using sterile water in place of dichlorophen and also with 
sterile water alone. One washed aliquot was subjected to 
grinding in a "Griffiths" tissue grinder. All the aliquots were 
filtered as before and the filters placed on nutrient agar. The 
results are shown in Table 10.
Table 10.
Numbers of bacteria in dichlorophen washed or unwashed larval 
suspensions and in washed larvae ground in Griffiths tube.
Treatment Suspension Dilution
1/10 1/100 1/1000
larvae + Panacide 0 0 0
larvae + water tmtc 62 4
larvae + Panacide 0 0 1
+ grinding
water alone 0  0 0
water + grinding 0  0 0
*
Single colony - regarded as extraneous contamination.
These results show that larvae treated with dichlorophen are 
bacteriologically sterile internally as well as externally.
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Discussion.
As predicted Dictol has been shown to contain contaminating 
bacteria. These include bacteria of enteric origin such as 
E.coli. The possibility that transmission of pathogenic bacteria 
could occur via Dictol undoubtedly exists. A system based on a 
one hour immersion of the larval suspension in a 0.0024% w/v 
solution of the sodium dichlorophen followed by washing with 
sterile water has proved to free the larval culture from 
bacteria. Larvae so treated have been shown to retain their 
infectivity. It therefore seems that dichlorophen treatment could 
be incorporated into the production process and possibly prevent 
Dictol being implicated in any outbreaks of bacterial disease.
In light of the results of the parenteral vaccination 
experiments outlined in chapter six, further sterility 
experiments were carried out and these are described in chapter 
seven.
Chapter Four.
Investigations into the usefulness 
of plastics for packaging lungworm vaccine.
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Since the introduction of Dictol by Allen and Hanbury's in 
1959 the presentation of the vaccine has remained virtually 
unchanged. About 24ml. of Dictol is bottled in 33ml. glass 
bottles with metal screw caps. This allows for a large bubble of 
air which aids in mixing the vaccine immediately prior to use. 
The bottles are of a convenient design for use. They are sturdy 
enough to not break easily. Also they have a small enough 
opening to enable the farmer to hold the bottle in one hand with 
his thumb across the mouth to prevent spillage while the other 
hand is free to open the calf's mouth.
The main drawbacks to using glass bottles are their weight 
and their relative fragility. To overcome the risk of breakage 
in transit Dictol is well packaged. Twelve glass bottles are 
placed in a plastic tray in a cardboard box. Batches of these 
small boxes are put into larger boxes and sealed with nylon-web 
tape. The individual 12-bottle boxes when full weigh about 950 
grammes of which 70% is made up of packaging (bottles plus box). 
This packaging obviously adds to the cost of producing the 
vaccine. The volume that packaged Dictol takes up when stored in 
the domestic refrigerator can also prove to be a nuisance.
If Dictol was packaged in bottles of a less fragile nature 
then the amount of cardboard and plastic protection could be 
reduced and production costs cut. For this reason replacing the 
glass bottles with unbreakable plastic bottles has been an 
attractive proposition. In the past, research at Ware has been 
carried out to examine the possibility of using polythene bottles 
or polypropylene bottles.
A study in 1968 of low density polythene bottles showed that
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it was impossible to get as many live larvae out of the bottles 
as were put in. Even soon after the bottles were filled, the 
delivery of live larvae from the polythene bottles was lower than 
that from glass. This drop in numbers of live larvae was not 
mirrored by an increase in the numbers of dead larvae but was 
found to be due to large numbers of larvae adhering to the sides 
of the bottles. It was reported at the time that these larvae 
were very difficult to remove from the plastic by brushing or 
shaking.
A further trial was performed in 1981 using polypropylene 
bottles. This trial gave more promising results than the 1 968 
polythene bottles trial. On the basis of the 1981 results a 
larger trial was carried out in 1982. Also calf protection 
experiments were planned and tooling costs were projected. 
However, this repeat trial was not as successful as the 1981 
trial. A large percentage of batches tested were deemed to be 
failures (i.e. delivered less than 40 larvae/ml.) and further 
investigation of polypropylene was suspended.
In the current work seven types of bottle were considered :
1) Glass - as currently used.
2) Polyvinyl chloride (P.V.C.) 30 ml.. Meason Freer Ltd.
3) P.V.C. 50 ml.. Meason Freer Ltd.
4) Polyethylene tetraphthalate (P.E.T.) Glaxo Operations Ltd.
5) Polypropylene ATO 3020. Rockware Plastics Ltd.
6 ) Polypropylene ATO 3020 + Clarifying Agent. Rockware Plastics
7) High Density Polythene. Rockware Plastics.
Before any experimental work was considered the high density 
polythene bottle was discarded as it was considered too opaque
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and too slippy to be of any practical use. The 50ml. P.V.C. 
bottle was considered too large and was also removed from further 
investigation.
The remaining five bottle types were used in the following 
trial. Five bottles of each type were filled by pipette with 
25ml. of a well mixed suspension of D.viviparus larvae. The 
bottles were stored at 4°C for one week. 1 ml. was removed from 
each of the bottles after thorough mixing and the number of 
larvae in that 1 ml. sample counted.
Results.
The results of this preliminary experiment are shown in 
Table 11. These are expressed as the number of larvae recovered 
per ml. from each of the five bottles followed by the mean and 
standard error for the group.
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Table 11.
The number of live larvae recovered per ml. from each of 
five bottles of each bottle type.
1) Glass.
48.0 43.4 44.0 44.4 45.6 mean = 46.2 + 1.5
2) P.V.C.
47.0 47.8 43.6 41.2 44.2 mean = 44.8 + 1.2
3) P.E.T.
46.2 43.4 45.6 47.0 46.8 mean = 45.8 + 0.7
4) Polypropylene.
38.2 38.2 39.6 39.2 46.2 mean = 40.3 + 1.5
5) Polypropylene + clarifying agent.
46.8 42.2 44.0 41.6 50.0 mean = 44.9 + 1.6
Following this preliminary trial it was decided that 
mimicking the production line fill process in the laboratory was 
not satisfactory. The previous work was therefore repeated using 
bottles filled on the Dictol production line at Ware.
Results.
The results of this trial are presented in Table 12. Again 
the mean number of larvae per ml. from each of four bottles of 
each type is listed along with the overall group mean and 
standard error.
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Table 12.
The mean number of larvae recovered per ml. from each of four 
bottles of the five bottle types under investigation.
1) Glass
76.0 64.2 84.4 67.0 mean = 72.9 + 4.6
2) P.V.C.
73.8 81.8 63.0 62.2 mean = 70.2 +_ 4.7
3) P.E.T.
67.8 89.2 71.8 92.4 mean = 80.3 ±  6.2
4) Polypropylene.
60.8 78.2 59.0 68.6 mean = 66.7 ±  4.4
5) Polypropylene + clarifying agent.
84.0 58.0 58.4 57.6 mean = 64.5 + 6.5
From these preliminary trials the most useful bottle type 
appeared to be the P.E.T.. A larger scale trial was performed to 
compare glass and P.E.T. bottles in greater detail. Both bottle 
types were filled on the production line and sent to Glasgow 
where the number of live larvae in five 1 ml. samples from each 
bottle was counted. 100 P.E.T. and 50 glass bottles were tested 
at 2 weeks after filling and 25 of each type tested at 5 weeks 
after filling.
Results.
The results of this trial are summarised in Table 13.
70
Table 13.
A summary of the results of the comparison study on 
P.E.T. and glass bottles.
2 weeks 5 weeks
glass P.E.T. glass P.E.T.
number of bottles 50 100 25 25
mean larvae/ml. 67.5 69.9 67.2 61.5
standard error 0.67 0.47 0.67 1.91
mean dead/ml. - - 3 . 3  3 . 6
std. error dead - - 0 . 2 2  0 . 2 1
The individual aliquot counts for these 200 bottles are
t
listed in the appendix along with their means.
The total volume of vaccine contained in each of 25 glass 
and 25 P.E.T. bottles was calculated using a 25 ml. glass 
pipette. The individual values are listed in the appendix but 
are summarised in Table 14.
Table 14.
The mean volume of vaccine contained in 
25 glass and 25 P.E.T. bottles.
glass P.E.T.
mean volume (ml) 24.1 21.3
standard error 0.07 0.39
range of values (ml) 23.4 - 24.6 18.8 - 24.0
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Ten of the P.E.T. bottles which gave the lowest number of 
larvae/ml. at week 5 above were emptied and cut open. The 
internal surfaces were examined microscopically for the presence 
of larvae adhering to the plastic. No such larvae could be 
found.
The data thus gathered were subjected to standard 
statistical analyses. Firstly it was necessary to show that all 
the sets of figures displayed normal distributions. This was 
essential if any parametric tests were to be subsequently 
employed. In a normal distribution >95% of the counts should lie 
in a range given by the mean +_ "t" times the standard deviation 
for the group, "t" was obtained by use of "t" tables at a 
probability of 0.05 and n-1 degrees of freedom (where n is the 
number of counts in the group). The calculations for the eight 
groups are given in the appendix. All the groups displayed 
normal distributions about their means.
The significance of differences between pairs of group means 
were calculated using students t-tests. The formula used was :
where : x = the group mean
n = the number in the group 
Sp = the pooled standard deviation 
Values for t were thus calculated and where t observed was 
greater than t at p = 0.05 and n1 + n2  - 2 degrees of freedom 
from t-tables, the difference was deemed to be significant. The
x 'i
sPv/vK
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individual calculations are in the appendix and are summarised in 
Table 15.
Table 15.
Summary of significance tests on means.
Glass 2 wks. v P.E.T. 2 wks. - P.E.T. significantly greater.
Glass 2 wks. v Glass 5 wks. - No significant difference.
P.E.T. 2 wks v P.E.T. 5 wks. - No significant difference.
Glass 5 wks v P.E.T. 5 wks. - Glass significantly greater.
There was no significant difference between the numbers of dead 
larvae in the bottles at 5 weeks.
When interpreting data such as that presented above, it is 
essential not to lose sight of the practical implications 
especially where significance tests have been applied. The 
difference between the means of the Glass and P.E.T. bottles at 2 
weeks is statistically significant showing P.E.T. to deliver more 
larvae per ml. In reality, however, the difference between the 
two means is only 2.4 larvae per ml. which would be of little 
significance in practice.
In contrast, the 8.4 larvae/ml. difference between the 
P.E.T. at 2 weeks and 5 weeks would at first glance appear to be 
important. Yet this is not significant statistically and is due 
to the very large range of values in the 5 week P.E.T. bottles. 
Since this variability is not caused by dead or adhering larvae 
it can only be accounted for by a greater variability in the
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number of larvae injected into the P.E.T. bottles at filling.
The figures for the total volumes of vaccine in the two bottle 
types show a wide variability in the P.E.T. bottles which is not 
present in the glass bottles. This directly reflects uneven 
filling on the production line. The filling machine at Ware has 
been designed to accommodate round, glass bottles. This it does 
very well, as is shown by the very small variation in the fill 
levels of the glass bottles. It does not, however, cope well with 
the P.E.T. bottles. Obviously if production was to switch to 
P.E.T. bottles the machine could easily be converted to produce 
consistent filling with these bottles. As it stands, the 
conclusion must be reached that the variability in results is due 
to the inconsistency at filling.
However, the fact remains that the P.E.T. bottles have 
performed well. There is no evidence to suggest that larvae die 
quicker in P.E.T. bottles than in glass. Nor is there any reason 
to suppose that fewer larvae can be recovered from these bottles 
than are originally put in. Indeed none of the bottles examined 
fell below the mean delivery of 40 larvae/ml. which Glaxo have in 
the past used as the criterion for success. Further testing 
would be necessary before retooling for P.E.T. could be 
recommended. Before any more work is done, however, some way 
will need to be found to eliminate the filling inconsistencies 
which undoubtedly exist.
Chapter Five.
A Freeze-dried Larval Vaccine.
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The cost of postage is one of the factors influencing the 
retail price of Dictol. It has been suggested that if both doses 
were despatched together then costs would be reduced. However, 
this would mean that the second dose would be at least 31 days 
old before it was used. While still within the licenced shelf- 
life, such storage would be undesirable. Even if the delay in 
usage could be reduced by shortening the time interval between 
the first and second doses, the presence of a large amount of 
Dictol in the domestic refrigerator for any length of time could 
prove unpopular.
One possible solution to this problem might be the use of an 
injectable dead vaccine to replace the second dose. It is known 
from earlier experiments (Jarrett et al. 1960) that a single 
intramuscular injection of a freeze-dried adult worm preparation 
confers a certain degree of immunity. While this immunity on its 
own is not sufficient to give calves a satisfactory degree of 
immunity to subsequent infection, it is possible that such an 
antigenic preparation superimposed on the partial immunity gained 
from a single oral dose of Dictol may boost the protection to 
adequate levels.
However, the use of adult worm extract as antigen is 
probably not a good commercial proposition. The collection of 
such material would necessitate the slaughter of infected calves, 
the cost of which would probably outweigh any savings made on 
postage and packaging. For this reason it was decided in the 
current experiment that any source of antigen would have to be 
the normal infective L^ .
If an L3 extract proved possible as a second dose an added
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benefit would be that such dead material could be manufactured
during the summer months when Dictol is not being produced. At 
present, production is concentrated within a few months with the
larval production capacity only ticking over in the remaining
part of the year.
In deciding the amount of material to use per dose, it was 
considered that the benefits would be lost if the 1 , 0 0 0  larvae 
oral dose had to be replaced by an extract from a massive number 
of larvae. For this reason a dose of 1,000 larvae or their 
equivalent was chosen.
It was further decided that freeze-drying was a convenient 
and very simple method of preparing the antigen and that as this 
was essentially a preliminary experiment no adjuvant should be 
included.
The possible injection routes were: intramuscular, 
subcutaneous, or intra-peritoneal. The intra-peritoneal route 
was considered undesirable. The other two routes seemed both 
equally easy and practicable and the subcutaneous was chosen.
Freeze-dried vaccine.
Aliquots of 1 000 normal D.viviparus L3 in 1 ml. distilled 
water were dispensed into 2ml. glass tubes and frozen in a -20°C 
freezer. Tubes of frozen larval suspension were then placed in a 
freeze-drier (Edwards, Crawley, England) overnight. Tubes were 
then stoppered and stored at 4°C until use. Immediately prior to 
use the doses of vaccine were reconstituted with 1 ml. sterile 
water and each was administered subcutaneously into the animal's 
right shoulder.
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Experimental Design.
15 male Friesian-cross calves were divided into 3 groups. 
Group One. Each of 5 calves were given normal oral doses of 
Dictol on Days 0 and 28.
Group Two. Each of 6 calves was given an oral dose of Dictol on 
Day 0 and a subcutaneous injection of 1,000 reconstituted freeze- 
dried larvae on Day 28.
Group Three. This group of 4 calves received no treatments on 
Days 0 or 28.
All calves were challenged with 30 I^/Kg on Day 56 and killed on 
Day 84.
Results.
At post-mortem, worm burdens and lung lesion scores were 
assessed. These are shown in Tables 16 and 17 respectively. 
The mean respiratory rates of the three groups are presented in 
Fig. 5.1.
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Table 16.
The post-mortem worm burdens of individual animals following 
challenge with 30 I^ /Kg. in groups given : 1) two doses of 
Dictol, and 2) one dose of Dictol followed by one dose of 
larval antigen, compared with 3) challenge only controls.
Group One Group Two Group Three
0 736 1110
0 385 1256
0 502 902
59 410 1844
413 820
*
mean 94.4 570.6 1278
protection 92.6% 55.4%
* This animal inhaled ruminal contents at after stunning, 
rendering estimation of worm burden unreliable.
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Fig.5.1. The mean respiratory rates, following challenge with 30 
D.viviparus L^/Kg. in groups of calves vaccinated with 1 ) two 
doses of Dictol or 2) one dose of Dictol followed by one dose of 
freeze-dried larvae, compared with 3) challenge only controls.
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Table 17.
The post-mortem lung lesion scores of individual animals 
following challenge with SOI^ /Kg. in groups given :
1) two doses of Dictol, and 2) one dose of Dictol followed 
by one dose of larval antigen compared with 
3) challenge only controls.
Group Two Group Three
2 *
2 2
3 2
3 3
4 
4
mean score 1 3 2.3
* This animal died prior to necropsy. Post-mortem changes in lung 
condition prohibited calculation of a lesion score.
Discussion.
In terms of worm burden, respiratory rate and lung lesions, 
Group One showed a response typical of double vaccination with 
Dictol. In contrast Group Three displayed the normal reaction of 
naive calves experiencing a large challenge infection. When worm 
burdens are expressed as a percentage reduction in "take" in the 
vaccinates relative to the controls, the Dictol group has 
performed well, the protection being 92.6%.
Group One 
0 
0  
1 
1 
3
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Group Two, the experimental group, did not perform so well. 
In terms of worm burden this group showed only a 55.4% reduction 
over the controls. The respiratory rates of this group did not 
reach the levels of the control group but neither did they show 
the decrease from around day 2 0  after challenge shown by the 
Dictol group. Also the degree of pulmonary consolidation was 
greater than that of the calves in Group One.
Obviously this vaccination regime could not be recommended 
as a replacement for the current vaccine. Indeed this experiment 
shows the necessity of the second vaccine dose. However, this 
work by no means exhausts the possibilities of a killed 
injectable second dose since only one means of antigen 
preparation was investigated and only one dose level tried. 
Possibly also, the incorporation of a suitable adjuvant would 
improve the degree of protection against challenge.
Chapter Six.
Parenteral Vaccination Experiments.
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Parenteral vaccination against infection with D.viviparus 
may have various advantages over oral vaccination not least of 
which is the greater ease of handling when larger calves are to 
be vaccinated. Three factors had now combined to make parenteral 
vaccination with live larvae worthy of closer investigation :
1) The evidence of Wade & Swanson (1958) that patent infections 
could be initiated by the parenteral injection of normal larvae.
2) The fact that farmers are now accustomed to using parenteral 
preparations themselves without veterinary supervision.
3) The techniques outlined earlier in this thesis which enable 
larvae to be made bacteriologically sterile and thus more 
acceptable for parenteral administration.
Guinea-pig Experiments.
Introduction.
Guinea-pigs have been widely used as experimental hosts for 
Dictyocaulus viviparus (Soliman 1953; Poynter et al. 1960; Wade, 
Fox and Swanson 1960 a; 1960b; Wade, Swanson and Fox 1961; Wilson 
1966). This species is routinely used by Glaxo Animal Health at 
Ware to assess the infectivity and attenuation of batches of 
Dictol. In the experiment outlined here, guinea-pigs were used as 
model hosts to investigate the infectivity of larvae when 
administered by the sub-cutaneous route.
Experimental Design.
Nine Duncan-Hartley guinea-pigs were divided into three 
groups.
Group One consisted of four animals. These each received one 
dose of 5,000 exsheathed third-stage larvae subcutaneously.
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Group Two was of two animals each receiving 5,000 normal L3  
subcutaneously.
Group Three had three animals. These were infected orally with
5,000 normal larvae and acted as controls.
Results.
The post-mortem worm recoveries are shown in Table 18.
Table 18.
The post-mortem worm burdens of guinea-pigs infected with :
1) 5,000 exsheathed D.viviparus L3 subcutaneously,
2) 5,000 normal L3 subcutaneously or
3) 5,000 normal L3 orally.
Group One Group Two Group Three
1 127 199
74 135 211
179 222
321
mean 144 131 211
recovery 2.9% 2.6% 4.2%
Discussion.
From the above experiment it was apparent that in 
guinea-pigs larvae were capable of migrating to the lungs after 
subcutaneous administration. Also this development was not 
dependent on prior exsheathment of the larvae.
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Calf Experiments.
Introduction.
The work of Wade & Swanson (1958) was carried out to 
investigate the possibility that lungworm disease in calves could 
be initiated by infection through the skin, either through wounds 
and insect bites or by the active penetration of larvae. In 
these experiments patent infections were achieved. However, 
several hundred thousand larvae were administered and it could be 
argued that the larvae which reached the lungs did so only by 
chance. It was therefore essential to attempt subcutaneous 
infection in calves using a modest number of larvae.
Experiment One.
In this preliminary experiment, one Friesian cross calf was 
injected in its right shoulder with 3,200 normal D.viviparus 
(30 1,3 /Kg).
Results.
A normal infection established in this calf. Faecal samples 
became positive for lungworm larvae on Day 28 and remained 
positive until Day 50.
Experiment Two.
Since this preliminary experiment suggested that a patent 
infection could be satisfactorily achieved with a moderate number 
of larvae, then it seemed possible that vaccination by the same 
route might also be possible.
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Experimental Design.
Nine Friesian cross calves were divided into 5 groups and 
treated with either one or two injections of irradiated third- 
stage larvae sub-cutaneously or intra-peritoneally as summarised 
in Table 1 9.
Table 19.
An outline of the design of Experiment Two.
Group No.of calves Day 0 Day 28 Day 56 Day
i 2 - s/c C K
ii 2 s/c s/c C K
iii 2 - i/p C K
iv 2 i/p i/p C K
V 1 C K
s/c = injection of 2,400 irradiated L3 sub-cutaneously. 
i/p = " 11 " " " intra-peritoneally.
C = Challenge with 30 L^ /Kg.
K = Kill
Results.
The post-mortem worm burdens of the five groups are shown in 
Table 20.
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Table 20.
The post-mortem worm burdens of calves vaccinated with one or two 
doses of irradiated larvae subcutaneously or intraperitoneally.
Group : i ii iii iv V
80 18 3 2 1393
264 109 300 790
mean 172 63.5 151.5 396 1393
protection 87.7% 95.4% 89.1% 71.6% —
Discussion.
From these results it appeared that double sub-cutaneous 
vaccination gave comparable protection to that which could be 
expected from oral Dictol. However, since little significance can 
be attached to the results of two calves, this vaccination regime 
was repeated on a larger number of animals.
Experiment Three.
In this experiment fourteen Friesian cross calves were 
divided into two groups.
Ten calves were given a sub-cutaneous injection of 1,000 
irradiated larvae on Days 0 and 28. These calves and 4 challenge 
controls were challenged with 30 I^/Kg. on Day 56 and killed on 
Day 84.
Results.
The post-mortem worm burdens are shown in Table 21, the lung 
lesion scores in Table 22 and the respiratory rates in Fig. 6.1.
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Table 21.
The post-mortem worm burdens of subcutaneously vaccinated calves 
challenged with SOI^ /Kg. compared with unvaccinated 
challenge controls.
Vaccinates Controls
0 514
0 946
0 1025
2 2250
2 
9 
34 
38 
150 
290
mean 52.5 1184.0
protection 95.5%
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Fig. 6.1. The mean respiratory rates following challenge with 30 
D.viviparus I^ /Kg. of a group of calves vaccinated subcutaneously 
with two doses of irradiated larvae, compared with challenge-only 
controls.
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Table 22.
The lung-lesion scores of subcutaneously vaccinated calves 
challenged with 30 I^ /Kg. compared with unvaccinated 
challenge controls.
Vaccinates : 1,1,1,1,1,1,2,2,3,3 mean =1.6 
Controls : 2,2,3,4 mean = 2.75
All controls showed a positive faecal larval count at 
necropsy compared with none in the vaccinates.
Discussion.
In terms of respiratory rate, worm burden, lung lesion score 
and faecal larval output, vaccination with two doses of 1 0 0 0  
irradiated D.viviparus L3 subcutaneously would appear to have 
been successful and gave a mean protection over controls of 
95.5%. Results from use of oral Dictol (quoted in Poynter, 1970) 
range from 8 8 .6 % to 99.6% protection. It is therefore reasonable 
to conclude that oral and subcutaneous administrations of live 
attenuated vaccine are equally effective.
Experiment Four.
While double sub-cutaneous vaccination had proved successful 
it was considered that a single dose vaccine would be 
advantageous. The original theory underlying Dictol was that the 
larvae should be attenuated in such a way that the majority died
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in the lymph nodes. Clearly though, significant numbers of the 
40Kr irradiated larvae reach the lungs (Poynter et al 1960). 
Perhaps if the dose of irradiation was increased, a greater 
percentage of larvae would die at an earlier stage of 
development in the lymph nodes and consequently be more 
immunogenic allowing a single dose vaccine to be effective. With 
oral vaccination, however, increasing the irradiation dose runs 
the risk of reducing the invasiveness of the larvae. With 
subcutaneous vaccination, such problems may be reduced.
It was decided, therefore, to carry out an experiment to 
further investigate the degree of protection afforded by a single 
subcutaneous dose of 40Kr irradiated larvae when compared with a 
single subcutaneous dose of larvae irradiated at a higher than 
normal level.
The simplest method of irradiation available was gamma- 
oirradiation from a ° Co source. A radiation dose of 70Kr was 
chosen which by the REE value of Kassai, Fitzpatrick & Mulligan 
(1966) would be equivalent to 49Kr from an x-ray source.
Experimental Design.
Twelve calves were divided into three groups.
Group One. Five calves were each given a single dose of Dictol 
sub-cutaneously. This was adjusted to 1500 L3  per dose.
Group Two. The four calves in this group were each given a 
single subcutaneous dose of 2000 L3 irradiated at 70Kr from 
a Cobalt source.
Group Three. Three calves served as challenge controls.
Groups One and Two were vaccinated on Day 0. All the calves
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were challenged with 5,000 L3 on Day 38 and killed on Days 63 - 
65.
Results.
The post-mortem worm burdens, faecal larval counts and lung 
lesion scores are shown in Tables 23, 24 and 25 respectively. 
The mean repiratory rates of the groups of calves are shown in 
Fig. 6.2.
Table 23.
The post-mortem worm burdens of calves challenged with 5,000
D.viviparus larvae following subcutaneous vaccination with a 
single dose of 40 Kr. irradiated larvae (Group One) or a single 
dose of 70 Kr. (cobalt) irradiated larvae (Group Two) compared 
with challenge-only controls (Group Three).
Group One Group Two Group Three
0 299 63
2 400 170
19 518 372
25 785
320
mean 73 501 202
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Table 24
The number of D.viviparus larvae per gramme of faeces at post­
mortem of calves challenged with 5,000 larvae following 
subcutaneous immunisation with a single dose of 40 Kr. irradiated 
vaccine (Group One) or a single dose of 70 Kr. (Cobalt) 
irradiated vaccine (Group Two) compared with challenge controls
(Group Three)
Group One Group Two Group Three
0 6
0 38 16
0 48 25
0 103
10
mean 2 63 16
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Fig. 6.2 The mean respiratory rates, following challenge with
5,000 D.viviparus L^ /Kg. of groups of calves vaccinated with 1) a 
single dose of 40Kr. irradiated vaccine or 2) a single dose of 
70Kr. (Cobalt) irradiated vaccine compared with 3) challenge-only 
controls.
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Table 25.
The post-mortem lung-lesion scores of calves vaccinated with a 
single dose of 40 Kr. irradiated larvae (Group One) or a single 
dose of 70 Kr. (Cobalt) irradiated larvae (Group Two) and 
subsequently challenged with 5,000 D.viviparus L3 compared 
with challenge only controls.
Group One Group Two Group Three
1 * 2
1 3 2
1 3 3
2 4
3
T3 13 23
Discussion.
Caution has to be exercised in the interpretation of the 
results of this experiment. The challenge controls, Group 3, 
showed poor worm burdens at post-mortem and this fact overshadows 
the results of the experimental groups. What can be definitely 
concluded is that single subcutaneous vaccination with 70Kr ^Co 
irradiated larvae afforded the calves no protection. This 
possibly suggests that the larvae were no longer sufficiently 
invasive to leave the injection site.
In Group One, four out of the five animals would appear to
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have been well protected against challenge. One can only 
speculate on the reason for the apparent failure of vaccination 
in the fifth calf; perhaps the most likely explanation is that it 
responded poorly due to innate unresponsiveness or to an 
infectious pneumonia. Overall, the percentage protection of Group 
One over the challenge controls was 64%. This is obviously a long 
way short of a satisfactory level of protection although this 
figure could be artificially low due to the very low "take" in 
the challenge controls. It is interesting that if the 4 animals 
with the lowest worm burdens are compared with the control group 
then the protection could be described as 94%.
From this experiment there is no firm evidence that a single 
subcutaneous injection of 40Kr x-irradiated larvae gives 
sufficient protection against subsequent challenge. However, a 
repeat of this experiment would be desirable before the use of a 
single dose of injectable vaccine is ruled out.
Chapter Seven.
The development of a sterile subcutaneous 
irradiated larval vaccine.
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The experiments described so far have shown that it is 
possible to produce a lungworm vaccine which is bacteriologically 
sterile and that live vaccine is equally effective whether 
administered orally or subcutaneously.
Although these conclusions indicate that a sterile, 
parenteral larval vaccine is feasible, the more stringent 
requirements of commercial production require the investigation 
of a number of further parameters.
For example, the sterilisation procedure would be 
considerably simpler if dichlorophen could be incorporated into 
the final vaccine, rather than using a system whereby the larvae 
are washed in dichlorophen and resuspended in sterile water. If 
this is possible it is obviously necessary to investigate the 
effect on D.viviparus larvae of prolonged exposure to 
dichlorophen.
This treated vaccine can at present only be described as 
"clean". In order to be marketed as a truly sterile preparation 
it would have to be shown to be free from all extraneous 
bacteria, fungi, mycoplasmas and viruses.
The final experiments outlined in this thesis were performed 
with four aims.
1) To provide further evidence of the degree of sterility of 
dichlorophen-treated vaccine in order to satisfy licencing 
requirements.
2) To prove the efficacy of dichlorophen-treated vaccine.
3) To test the safety of dichlorophen-treated vaccine.
4) To compare the shelf-life of dichlorophen-treated and
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untreated larvae.
STERILITY.
New veterinary products must conform to the guidlines laid 
down by the British Pharmacopoeia, the British Veterinary 
Pharmacopoeia and the European Pharmacopoeia. In this respect a 
prescribed number of samples from each batch of a particular 
product must be tested and shown to be free from any 
contaminating organisms. Dictol was first marketed in 1959, 
before the Veterinary Products Committee (VPC) came into being. 
It, therefore, has a "licence of right" in that it has never been 
assessed by the VPC and has consequently never been asked to 
conform to the sterility guidlines. If, however, the product 
licensing authorities were to reassess Dictol it seems likely 
that they might insist on sterility. Furthermore, while the 
pharmacopoeiae only require a product to be demonstrably free 
from contamination, it is possible that the authorities would 
like it proven that pathogens accidentally introduced into the 
vaccine are removed by the production process. To this end 
therefore, experiments were carried out where vaccine was 
artificially contaminated with potential pathogens, subjected to 
the usual treatment process as would occur in the factory and 
then assayed for the pathogen. Experiments with virus 
contamination were undertaken in conjunction with Professor 
0. Jarrett of the Department of Veterinary Pathology, Glasgow 
University and experiments on bacterial contamination with Dr. H.
i
Birkbeck of the Microbiology Department, Glasgow University.
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BACTERIOLOGY.
The experiments in Chapter 3 showed that a one hour wash in 
0.0024% w/v dichlorophen rendered third stage Dictyocaulus larvae 
sterile.
Following discussions with the manufacturers of Panacide, 
BDH, (Purkiss, personal communication) it became clear that a 
higher dichlorophen dilution might be desirable. Purkiss 
suggested that the most difficult organism to kill with 
dichlorophen would be Pseudomonas spp. and recommended a 0.009% 
w/v dichlorophen solution. However it was thought that the 
lowest effective concentration should be used in order to 
minimise the risk of reducing the infectivity of the larvae. A 
0.004% w/v solution was therefore chosen.
Initially dichlorophen was added to three bottles of Dictol 
to a final concentration of 0.004% w/v. These were left at 4°C 
for 24 hours and then the total contents of each bottle filtered 
on to separate cellulose acetate filters; this process of 
filtration was repeated with three control bottles of Dictol. 
The filters were incubated in thioglycolate medium for seven days 
as recommended by the British Pharmacopoeia. Bacterial growth was 
observed in the three control flasks but no growth occurred from 
the three treated bottles. This showed that incorporation of 
0.004% w/v dichlorophen rendered Dictol bacteriologically sterile 
after 24 hours at 4°C.
Following this, it was decided to show if such treatment 
would kill 100% of deliberately added bacteria. Suspensions of
E.coli were made up at 10^ , 10^ and 10^ organisms per ml. of
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sterile distilled water. To aliquots of each bacterial 
suspension was added dichlorophen to give a final concentration 
of 0.004% w/v dichlorophen. All bacterial suspensions were 
stored at 4°C for 24 hours. Duplicate bacterial suspensions in 
sterile water acted as controls. Again these were filtered and 
grown in thioglycollate medium for seven days.
No growth was apparent in the dichlorophen treated aliquots 
whereas growth occurred in all the controls.
This above procedure was repeated using Pseudomonas 
aeruginosa added to Dictol giving final concentrations of 10^ ,
1 0 J and 1 0  bacteria per ml. of vaccine in the presence or 
absence of 0.004% w/v dichlorophen. Again incubation at 4°C for 
24 hours was followed by filtration and incubation. Growth was
p
seen in all the cultures with the exception of the 1 0  bacteria 
per ml dichlorophen treated vaccine. Clearly then, 24 hours at 
4°C was insufficient to kill large quantities of artificially 
introduced Pseudomonas.
It seemed probable that the bactericidal action of 
dichlorophen could be improved by increasing the temperature or 
by lengthening the incubation period prior to filtration. Again 
Pseudomonas was added to Dictol at 10^ , 10^  and 10^  organisms/ml. 
in the presence or absence of dichlorophen. Duplicates were 
incubated at 20°C for 24 hours and 4°C for 40 hours. As before, 
following incubation, these were filtered and the filters 
incubated in thioglycollate. Bacterial growth was observed in 
all the controls and in the highest bacterial concentration (1 0 )^ 
of the 4°c incubated group.
It was becoming evident that to kill efficiently
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large numbers of added Pseudomonas, vaccine would either have to 
be left at room temperature for a period of 24 hours or remain at 
4°C for a prolonged period.
In the normal course of events, Dictol is left at ambient 
temperature from the time that the bottles are filled until the 
day's bottling is completed and the pallets of boxed vaccine are 
put into a 4°C store. Vaccine is despatched from this store 
after anything from 18 hours to 7 days. It can be safely assumed 
that no vaccine is used before four or five days after filling.
A sterilising regime which relied on vaccine remaining at 
20°C for 24 hours could not be recommended as it may have an 
adverse effect on the longevity of the larvae. Similarly a 
prolonged treatment at 4°C might mean that a heavily contaminated 
batch of Dictol would be at the farm before it could be 
guaranteed sterile. Increasing the dichlorophen concentration 
was also thought undesirable and would have necessitated 
repeating the safety/efficacy work which was already in progress. 
A compromise was therefore investigated whereby 0.004% w/v 
dichlorophen treated vaccine would be incubated at room 
temperature for 6 hours followed by three days storage at 4°C.
Initially an unopened box of Dictol was selected and to ten 
of the bottles was added 240 ul of 0.4% w/v dichlorophen giving a 
final dichlorophen concentration of 0.004% w/v. The remaining 
two bottles were untreated and acted as controls. All the 
bottles were left at room temperature for 6 hours and then placed 
in a 4°C fridge for 3 days. At the end of this time all the 
bottles were filtered and the filters incubated as before. There
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was no growth in the dichlorophen treated bottles compared with 
heavy growth in the two controls.
This procedure was repeated with Pseudomonas aeruginosa 
added at 10^ organisms/ml vaccine. As before the ten 
dichlorophen treated and two control bottles were left at room 
temperature for 6 hours followed by 4°C for 3 days. Again, 
following incubation of filters in thioglycollate broth, 
bacterial growth was only observed in the controls.
This last experiment showed that a technique had been 
devised which could kill 1 0 0 % of a large volume of an 
artificially added contaminant which is known to be relatively 
highly resistant to the bactericidal action of dichlorophen. It 
now seemed sensible to test this protocol against a range of
potential pathogens chosen to represent the major groupings of
bacteria. Since the results of these experiments would be likely 
to be submitted to the Ministry of Agriculture it was thought 
essential to use specified strains of bacteria obtained from the 
Central Public Health Laboratory's National Collection of Type 
Cultures.
To this end therefore, the following organisms were 
selected:
Escherichia coli........ NCTC 9002
Salmonella abony. NCTC 6017
Pseudomonas aeruginosa.... NCTC 6750
Clostridium perfringens... NCTC 8237
As before the organisms were added to unopened bottles of 
vaccine to a final concentration of 10^  organisms per ml. Twelve 
bottles were inocculated with each species of bacterium. To ten
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of the bottles was added dichlorophen to a final concentration of 
0.004% w/v. The remaining two bottles acted as controls.
The results of this test are shown in Table 26.
Table 26.
The sterility of dichlorophen treated vaccine following the 
addition of 10^  bacteria per ml. and incubation at 20°C for 
6 hours and 4°C for 72 hours.
Bacterium added 
E.coli 
S.abony 
Ps.aeruginosa 
Cl.perfringens
number of bottles sterile 
10/10 
10/10 
10/10 
10/10
The dichlorophen-treated vaccine was found to be free from 
contamination in every case. All the controls gave heavy 
bacterial growth.
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VIRUS EXPERIMENTS.
The problem of virus contamination in Dictol is in a sense 
less serious than that of bacterial contamination. Unlike many 
bacteria, viruses are unable to replicate in a cell-free medium. 
Their numbers are therefore unlikely to increase during storage 
of Dictol. In addition, certain viruses quickly lose infectivity 
when suspended in water. However, it must be appreciated that 
these viruses which can survive long periods outwith the host are 
extremely resistant to killing by chemical means.
The initial isolation of larvae from faeces depends on 
migration of larvae to the surface of the faecal pat. This stage 
alone ensures that larvae are selected out of the vast bulk of 
any pathogens in the faeces. After this there follows a process 
of various stages of filtration, migration and sedimentation. The 
amount of water used in this process is unknown (Jenkins, 
personal communication.) but represents a quite considerable 
dilution of the faecal matter. The final dilution from the 
irradiation vial to bottling is, however, quantifiable and at 
peak production is typically about 1:40,000. It is considered 
that this final dilution would effectively reduce any viral 
contamination to below detectable and infective levels.
There were two principal objectives to the virus experiments 
which are outlined here. Firstly it was decided to determine the 
amount of viricidal action which dichlorophen itself possesses. 
The second objective was to examine the combined effect of 
washing the larval suspension with a large volume of water 
followed by the addition of dichlorophen to the final suspension. 
To do this, selected viruses would be required to be added to a
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suspension of irradiated larvae; the suspension would then be 
washed with a large volume of water and after sedimentation to 
the original volume, dichlorophen added in order to mimic the 
likely production process. At the end of this process the 
vaccine would be examined for presence of virus.
Experiment One.
Dichlorophen is reported to have a certain amount of action 
against lipophilic viruses such as Newcastle disease virus 
(Purkiss, BDH - personal communication). It was therefore 
decided to assess the activity of dichlorophen against the 
lipophilic IBR virus.
Three vials were prepared. One contained cell-culture 
medium, one had 0.005% w/v dichlorophen in water and the
remaining vial contained 0.01% w/v dichlorophen in water. To
£
each was added c2.0 x 10° infectious units of IBR virus per ml. 
These were stored at 22°C and assayed for virus at 0, 3 and 24 
hours.
Results.
The level of virus at the three time intervals in the three 
groups are shown in Table 27.
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Table 27.
The virucidal activity of dichlorophen against IBR virus.
Group
plaque forming units virus per ml. at time. 
0 hours 3 hours 24hours
Control 2.2 x 106 8.0 x 105  1.3 x 106
0.005% w/v 1.4 x 106 1.8 x 105  4.0 x 104
0 .0 1 % w/v 1 . 2  x 1 0 6 3 . 0  x 1 0 4  7 . 0  x 1 0 2
Discussion.
These results show that at 24 hours dichlorophen reduced the 
level of virus by 1 0 4 in the higher dichlorophen concentration 
and by 10 in the lower dichlorophen concentration. While this 
activity is quite considerable it is probably insufficient alone 
to render an artificially contaminated bottle of Dictol sterile.
Experiment Two.
The second virus experiment was carried out to examine the 
combined effect of dichlorophen treatment and the dilution factor 
in the production process. While the estimated dilution factor 
between irradiation and bottling was about 1:40,000 for oral 
vaccine this would fall to about 1 :2 , 0 0 0  for an injectable 
preparation due to the smaller final volume. This dilution 
factor was therefore chosen in the following experiment.
Design.
Approximately 10 infectious units of IBR virus were added
to two standard bottles of Dictol. One of these was diluted 
1 :2 r0 0 0  with distilled water by a process of centrifugation and 
supernatant replacement. 240ul of 0.4% w/v dichlorophen was 
added to give a final concentration of 0.004% w/v. Both bottles 
remained on the bench for 6 hours followed by three days at 4°C. 
After this time both bottles were assayed for the presence of 
virus.
Results.
No virus was isolated from either bottle.
Discussion.
This experiment showed that the viricidal effect of low 
temperature storage in water was sufficient to reduce 
contamination to below detectable levels. It would also suggest 
that the margin for safety in the diluted and dichlorophen 
treated bottle must be extremely large.
Experiment Three.
The above experiment was repeated using Bovine Virus 
Diarrhoea virus (Mucosal Disease Virus) in place of IBR virus. 
Again, 10^  infectious units of virus were added to two bottles of 
Dictol. One of these was diluted and treated with dichlorophen 
as above. Both were incubated for 6 hours at 22°C and three days 
at 4°C.
Results.
Again no virus could be isolated from either bottle.
109
Discussion.
The experiments outlined above show that if IBR or BVD virus 
was present in the larval suspension, dilution in water alone 
without the addition of dichlorophen will prevent the virus from 
being present in the final vaccine. However, this work will need 
to be repeated with such other viruses as are suggested by the 
Ministry of Agriculture.
One possibility that has yet to be investigated is that 
viruses could be present within the larvae. It is known that 
Metastrongylus apri larvae harbour the virus which causes swine 
influenza and act as a method of transmission for this virus from 
pig to pig (Shope,R.E., 1943, J. Exp. Med. 77 111-38). 
Experiments to rule out the presence of viruses in Dictyocaulus 
larvae would be extremely difficult to carry out and were 
considered beyond the scope of the current work.
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EFFICACY EXPERIMENT.
The commercial success of oral Dictol has been mainly 
founded on its known high efficacy in protecting against clinical 
parasitic bronchitis. It now appeared that a parenteral 
preparation could be as effective as the oral product. However, 
no experiments had been carried out to test that dichlorophen- 
treated vaccine was as effective as untreated vaccine. To this 
end, therefore, the following experiment was carried out to 
determine the level of protection conferred by sterile injectable 
and sterile oral vaccination.
Design.
Eighteen cross calves were divided into three groups of six 
calves.
The calves in Group One were each vaccinated orally with
1,500 dichlorophen-treated, irradiated larvae on days 0 and 28.
The calves in Group Two were each vaccinated subcutaneously 
with 1,500 dichlorophen-treated, irradiated larvae on days 0 and 
28.
The calves in Group Three remained unvaccinated and acted as 
challenge controls.
All three groups of calves were challenged with 3,000 normal 
lungworm larvae on day 56 and killed on days 80 and 81.
Results
i) Vaccination.
No adverse reactions were noted at the sites of subcutaneous 
vaccination.
Transient periods of coughing were noted amongst both groups 
of vaccinated calves. An independent assessment of the degree of
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coughing suggested that this was greatest in the orally 
vaccinated group.
ii) Respiratory Rates.
The mean respiratory rates of the groups of calves in this 
experiment are shown in Fig. 7.1. Following challenge, the 
respiratory rates of the calves in Group Three rose earlier, 
reached a higher peak and decreased more slowly than those of the 
two vaccinated groups. No difference was observable between the 
two vaccinated groups.
iii) Post-mortem Worm Counts.
The worm burdens of the 18 calves are listed in Table 28.
The post-mortem worm burdens of calves challenged with 3,000 
lungworm larvae following oral vaccination (Group One) or 
subcutaneous vaccination (Group Two) compared with
Table 28
unvaccinated controls (Group Three)
Group One 
(Oral vacc'n)
Group Two Group Three 
(s/c vacc'n) (controls)
100
130
0
0
0
16
110
0
3
4 
18 
25
864
1062
1140
1149
1275
1655
mean 41 26.7 1190.8
protection 96.6% 97.8%
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Fig. 7.1. The mean respiratory rates, following challenge with
3,000 D.viviparus L3 of groups of calves vaccinated with 1) 
sterile oral vaccine or 2 ) sterile subcutaneous vaccine compared 
with 3) challenge-only controls.
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iv) Faecal Larval Output
The mean output of lungworm larvae per gramme (lpg) of 
faeces at post-mortem in each group was as follows :
Group One (oral vacc'n).............. 1 lpg
Group Two (s/c Vacc'n)...............0 lpg
Group Three (controls)............ 87.4 lpg
v) Lung Lesion Scores
The degree of lung damage based on a lesion score of 0-5 is 
shown in Table 29.
Table 29.
The estimated lung-lesion scores of calves challenged with
3,000 lungworm larvae following oral vaccination (Group One) 
or subcutaneous vaccination (Group Two) compared with 
unvaccinated controls (Group Three).
Group One Group Two Group Three
(oral vacc'n) (s/c vacc'n) (controls)
1 1 3
1 1 3
1 2 4
1 2 4
3 2 4
5 3 5
mean 2.0 1.8 3.8
vi) Calf 8 8
One calf from the orally vaccinated group was killed in-
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extremis on day 77 (21 days after challenge). At necropsy very 
few adult worms were found in the lungs. The lungs were 
oedematous and showed a very severe degree of consolidation 
although this was diffuse (rather than lobular as might be 
expected). No vaccination/challenge lymphoid nodules were 
observed.
Discussion.
In terms of respiratory rate, post-mortem worm burdens, 
faecal larval output and lung lesion score, the two vaccinated 
groups showed a considerable degree of protection against 
challenge. It can therefore be concluded that dichlorophen- 
treated vaccine is as immunogenic as the current product and that 
subcutaneous vaccination is as effective as oral vaccination.
While in terms of worm burden, larval output, lesion score 
and degree of post-vaccination coughing, the subcutaneously 
vaccinated group appeared to have performed better than the oral 
group, it is unlikely that the differences between these two 
groups are significant.
The reason for the adverse reaction in calf 8 8  is obscure. 
It would appear possible, based on the histological findings of 
alveolar epithelialisation and worm debris, that this was a 
response similar to that seen in the reinfection syndrome and was 
a reaction to worm material in the lungs.
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SAFETY EXPERIMENT.
This experiment was designed to investigate the safety of 
the sterile injectable lungworm vaccine should the occasion arise 
where calves were inadvertently exposed to more than the stated 
dose of vaccine.
Design.
Four Friesian-cross calves were divided into two groups of 
two calves.
The calves in Group One were injected subcutaneously in 
their right shoulders with 3,000 dichlorophen-treated, irradiated 
D.viviparus L3 .
The calves in Group Two were injected subcutaneous ly with
4,500 dichlorophen-treated, irradiated larvae.
All animals were killed on Day 27.
Results.
i) Injection site.
The injection itself did not appear to cause the animals any 
pain nor was any irritation noticeable immediately following 
vaccination.
No adverse reactions were noted at the injection sites 
during the course of the experiment or at post-mortem.
ii) Respiratory rates.
The mean respiratory rates of the groups of animals in this 
experiment are shown in Fig. 7.2. The respiratory rates of the 
animals in both groups rose from day 1 0  after vaccination and
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Fig. 7.2. The mean respiratory rates, following vaccination of 
groups of calves given 1) 3,000 irradiated larvae subcutaneously 
or 2) 4,500 irradiated larvae subcutaneously.
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reached a peak at day 15. Thereafter the respiratory rates 
gradually declined.
iii) Worm counts.
The post-mortem worm burdens of the 4 animals were as 
follows :
Group One 0 1
Group Two 1 16
All the worms recovered were extremely small (< 1 cm in length)
and were all sterile females.
iv) Lung condition at necropsy.
The lungs of all the calves showed small patches of 
consolidation in the diaphragmatic lobes. The lesion scores (on 
a scale of 0 - 5 depending on degree of consolidation) were as 
follows :
Group One 1 1
Group Two 1 2
Discussion.
The two doses of vaccine used in this experiment were chosen 
to represent 2 times and 3 times the normal vaccine dose. Both 
these doses of vaccine were sufficient to cause a marked increase 
in respiratory rate. However, neither proved fatal and at no 
time were the animals in great distress. The condition of the 
lungs of these animals at necropsy was reasonably good and it 
could be concluded that these excessive doses of vaccine would 
not cause any permanent harm to the animals.
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VIABILITY EXPERIMENTS.
Finally, having found a system by which vaccine could be 
made sterile and a new means of administration for this vaccine, 
it was essential to prove that neither the sterilant nor the 
necessarily increased larval concentration in an injectable 
preparation had any detrimental effects on the long term 
viability or infectivity of the larvae.
Design.
On Day 0 suspensions of larvae were made up and bottled as 
follows :
1 ) 1500 L3 in 2ml distilled water.
2) 1500 L3 in 2ml 0.004% w/v dichlorophen.
3) 1500 L3 in 25ml distilled water.
4) 1500 L3 in 25ml 0.004% w/v dichlorophen.
Twelve duplicates of each was made up and these were stored at 
4°C until use.
On Days 8 , 18, 26 and 42 one bottle from each group was
examined microscopically and an estimate of the viability of the
larvae was made.
On day 7, six calves were infected as follows:
1) One calf received two doses of the larvae stored in 2ml 
distilled water.
2) Two calves each received two doses of the larvae stored in 2ml 
0.004% w/v dichlorophen.
3) One calf received two doses of the larvae stored in 25ml 
distilled water.
4) Two calves each received two doses of the larvae stored in
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25ml 0.004% w/v dichlorophen.
Each calf therefore received 3000 larvae.
The above procedure was repeated with a further six calves 
on day 42 of the experiment. All calves were slaughtered 28 days 
after infection.
Results.
i) Microscopic viability estimation.
The percentage viability of the larvae at the various 
sampling dates is shown in Table 30.
Table 30.
The percentage viability of dichlorophen-treated 
or untreated larvae stored in 2ml vials or 25ml bottles.
Group
Day 2ml
untreated
2ml
treated
25ml
untreated
25ml
treated
8 94.4 95.2 98.6 94.8
18 90.8 94.6 93.0 96.8
26 95.4 98.1 84.0 94.1
42 91.2 94.6 87.7 90.7
These figures show no appreciable loss of viability of 
larvae stored in a 0.004% w/v. solution of dichlorophen for 42
120
days as compared to the controls stored in water. Also, storage 
in 2ml vials rather than 25ml bottles would not appear to have 
had any adverse effect on the estimated viability.
ii) Infectivity results.
Respiratory Rates.
The respiratory rates of the individual animals all showed 
increases over the experimental period typical of lungworm 
infection and displayed little variation between groups or 
periods of storage. See Figures 7.3 and 7.4.
Post-mortem worm counts.
The post-mortem worm burdens of the calves in this 
experiment are shown in Table 31.
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Fig. 7.3. The mean respiratory rates of groups of unvaccinated 
calves following challenge with 3,000 D.viviparus L3 stored for 7 
days 1) as 750 L^/ml in distilled water, 2) as 750 L^/ml in 
0.004% w/v dichlorophen, 3) as 60 L^/ml in distilled water or 4) 
as 60 I^/ml in 0.004% w/v dichlorophen.
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Fig. 7.3. The mean respiratory rates of groups of unvaccinated 
calves following challenge with 3,000 D.viviparus stored for 7 
days 1) as 750 L^/ml in distilled water, 2) as 750 L^/ml in 
0.004% w/v dichlorophen, 3) as 60 L^/ml in distilled water or 4) 
as 60 L3 /1T1I in 0.004% w/v dichlorophen.
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Table 31.
The post-mortem worm burdens of calves infected with 3000 
lungworm larvae which had been stored for 7 or 42 days in 
2ml vials or 25ml bottles of dichlorophen or water.
Group Day 7 Inf'n. Day 42 Inf'n.
1) 2ml untreated 236 *1000
2) 2ml treated 440 395
*629 300
3) 25ml untreated 694 383
4) 25ml treated 562 32
457 3
* These calves were slaughtered in extremis during pre-patency 
and worm recoveries were performed using a different technique to 
that employed for the other calves whereby the lungs were floated 
in warm saline to recover the smaller worms.
All calves exept those killed early showed positive faecal 
samples at post-mortem.
The worm numbers recovered from Groups 1 and 2 at day 7 and 
day 42 infections were all within the range that might be 
expected and showed no significant reduction over the six week 
shelf-life. The two highest counts were from animals which were 
killed in pre-patency and the larger number of worms present 
probably reflect the technique required to recover worms at this
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stage.
The worm recoveries from Groups 3 and 4 showed no 
difference at day 7 but a considerable reduction in infectivity 
at day 42 in the dichlorophen treated group. This reduction in 
infectivity was not mirrored by a reduction in the 
microscopically estimated viability for this group. The reasons 
for this are obscure.
This experiment showed that larvae prepared for use as a 
sterile injectable vaccine did not suffer any shortening of 
shelf-life. However, the inexplicable drop in the infectivity of 
larvae prepared as for a sterile oral vaccine required further 
investigation and to this end the following experiment was 
carried out.
Design.
25ml. aliquots of a 60 L3 /111I. suspension of normal lungworm 
larvae were made up on day 0. To these was added either 250 ul. 
distilled water or 250 ul. 0.4% w/v dichlorophen.
ii) On day 35 two calves were each given two dichlorophen- 
treated aliquots (Group One).
iii) On day 44 two calves were each given two dichlorophen- 
treated aliquots (Group Two).
Also on day 44 two calves were each given two of the 
untreated aliquots (Group Three).
Each calf therefore received 3,000 larvae.
iv) All calves were killed on day 64.
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Results.
i) Respiratory Rates.
The respiratory rates of the groups of calves in this 
experiment are shown in Figure 7.5. All calves showed increases 
in respiratory rates typical of lungworm infection.
ii) Post-mortem Worm Counts.
The post-mortem worm burdens are shown in Table 32.
Table 32.
The post-mortem worm burdens of calves infected on 
day 35 or 44 with treated or untreated larvae.
Group One Group Two Group Three
Day35(treated) Day 44(treated) Day 44 (untreated)
527 320 360
901 470 369
mean 714 395 365
iii) Microscopically determined viability.
The viability of the larvae were assessed microscopically at 
intervals throughout the experiment. These results are shown in 
Table 33.
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Fig. 7.5. The mean respiratory rates of groups of unvaccinated 
calves challenged with 3,000 D.viviparus which had been stored 
1) for 35 days at 60 L^/ml in 0.004% w/v dichlorophen, 2) for 42 
days at 60 L^/ml in 0.004% w/v dichlorophen or 3) for 42 days in 
distilled water.
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Table 33.
The percentage viability of dichlorophen treated 
or untreated larvae stored at 60 L3 /111I.
Day Treated Untreated
0 97.3 94.1
13 78.8 90.4
26 74.2 91.1
35 69.6 84.2
44 68.4 81.6
Discussion
The infectivity and viability of Dictyocaulus larvae are 
reduced following prolonged storage. The worm burdens of the 
animals challenged with day 44 larvae are approximately 30% of 
the burdens that might be expected from a challenge of 3,000 
fresh larvae (c.f. challenge controls in the efficacy experiment 
where mean =1191 worms). In terms of worm burden, however, it 
would appear that the infectivity of the larvae is not adversely 
affected by the presence of dichlorophen.
In contrast, the viability as determined microscopically is 
reduced to a greater degree in the dichlorophen-treated group 
than in the untreated group. The fact that this is not reflected 
in the infectivity results possibly highlights the unreliability 
of viability testing. However, even at day 44 in the 
dichlorophen-treated larvae the 68.4% viability still leaves
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>1,000 live larvae per bottle and is above the 40 viable larvae 
per ml. cut-off point used in the past by Glaxo as a criterion of 
success (R.Peacock, Glaxo internal report 7/5/82).
It would appear that the dichlorophen incorporation does not 
greatly harm the larvae even after 44 days. Clearly the real test 
of this is to examine the efficacy of treated vaccine after 
various periods of storage.
Chapter Eight.
Final Discussion and Conclusions.
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The bulk of this thesis has been concerned with the 
development of a sterile irradiated lungworm vaccine for 
administration by the oral or subcutaneous route.
Originally, sterility was achieved by means of a one hour 
wash in a 0.0024% w/v solution of sodium dichlorophen followed by 
suspension in sterile water and bottling in sterile containers by 
aseptic means. While this system had the desired effect of 
producing vaccine from which no extraneous bacteria could be 
isolated, the extra washing involved made this technique 
cumbersome. In addition, further information from BDH, the makers 
of Panacide, suggested that a higher concentration of 
dichlorophen would be required if it was necessary to cope with a 
greater degree of contamination. An improved technique was 
therefore devised whereby a higher concentration of dichlorophen 
(0.004% w/v) was added and this remained in the vaccine until 
use. In this way the dichlorophen had a longer time in which to 
effect the sterilisation of the vaccine. In theory this 
technique would also reduce the need for sterile bottling 
facilities although in practice it is possible that this will be 
required in order to gain a product licence.
The efficacy of this sterilisation regime was tested by 
adding organisms to vaccine, adding dichlorophen and then 
assaying for the organisms after a period of incubation. 
However, the bactericidal effect of a predetermined concentration 
of dichlorophen varies with the period of contact with the 
organisms, the temperature and the number of organisms present. 
In order to subject the procedure to a realistic level of
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contamination, 1 0  ^bacteria were added per ml. of final vaccine. 
Taking into account the dilution factor between irradiation and 
bottling, this level of contamination is the equivalent of at 
least 80 million bacteria per ml. of larval suspension (3,000 
times greater than the actual contamination level determined in 
Chapter Three).
The incubation temperature was chosen to mimic the 
production process. Vaccine storage is at 4°C, a temperature at 
which dichlorophen is slowly bactericidal. If dichlorophen is 
added at the point where the irradiated larval suspension is 
diluted to form the final vaccine, it is estimated that the 
vaccine/dichlorophen mix will have 6 hours at ambient temperature 
prior to storage in a room held at 4°C. On the basis of this 6  
hour room temperature incubation followed by 4°C storage, it was 
found that this regime successfully kills 1 0 0 % of added bacterial 
contaminants.
In addition, it was shown that this regime also kills 
artificially added Infectious Bovine Rhinotracheitis virus and 
Mucosal Disease virus. The evidence so far suggests that this 
treatment does not significantly impair the shelf-life of the 
vaccine.
While it is envisaged that dichlorophen would only be 
introduced at the final stage where larvae are diluted following 
irradiation, it may be necessary for licensing reasons to add 
dichlorophen at an earlier stage. For example, dichlorophen 
could be present in all water used in the production process from 
the time when the larvae are first washed off the surface of the 
faeces right through to bottling. This would result in the use
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of large volumes of dichlorophen and inevitably increase the cost 
of production.
Perhaps, a suitable compromise would be that dichlorophen 
could be used in all the water from the 2 nd migration stage 
onwards. This is the final washing stage by which time 
production has moved to Ware, whereas the earlier stages are at 
Bury Green and Lady Hayes farms. In addition 0.22um pore size 
cartridge filters could be built in to the water supply systems 
at all 3 locations to ensure that all the water used in the
production process was itself sterile.
The experiments described in Chapters 6  and 7 have shown
that a live subcutaneously administered vaccine is as protective 
as the existing oral preparation. Initially, having confirmed 
that D.viviparus L3 are infective when injected subcutaneously, 
the relative protection afforded by one or two doses of 2,400 
irradiated larvae administered subcutaneously or intra- 
peritoneally was investigated in groups of two animals per 
treatment. While all regimes gave protection (the minimum being 
72% for the double intra-peritoneal injection) it was found that 
double subcutaneous vaccination gave 95.4% protection. A second 
experiment with 1 0  calves vaccinated subcutaneously with two 
doses of 1,000 irradiated larvae gave 95.5% protection against 
challenge.
Further investigation of single dose subcutaneous 
vaccination with 40Kr x-irradiated or 70Kr gamma-irradiated 
larvae gave inconclusive results due to a poor establishment in 
the challenge only controls.
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A final protection experiment was carried out in Chapter 7 
comparing dichlorophen-treated subcutaneous vaccine with 
dichlorophen-treated oral vaccine and challenge only controls. 
Groups of six calves showed that subcutaneous vaccination gave 
97.8% protection and oral vaccination 96.6%.
A total of 18 calves in three experiments have therefore 
been vaccinated subcutaneously and in these the groups have given 
mean levels of protection between 95.4% and 97.8%.
The principal advantages of such an injectable vaccine are 
twofold. Firstly there is the ease of handling. With the 
current product the calf must be restrained while its head is 
held up, its mouth opened and the vaccine poured down the throat. 
While this is normally quite easy with pail fed, 10 week old 
dairy replacement calves, it is more difficult to perform the 
same task on autumn bom suckler calves which are perhaps 5  or 6  
months old at vaccination and not used to being handled. This is 
especially difficult if no crush is available. In contrast such 
calves can be tightly penned and injected with much less fuss.
The second advantage of an injectable vaccine is the 
certainty that the whole dose of vaccine has been administered. 
With oral vaccination, there is the risk of the animal not 
swallowing the whole dose or of spillage by the person performing 
the vaccination.
If both oral and injectable products were available the 
farmer would be able to choose the system best suited to his 
needs.
There are also several purely commercial, perhaps 
unscientific, advantages in having a sterile oral/injectable
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vaccine. The very fact of having a "new" vaccine lends a 
marketing advantage over any competition. In addition, if it is 
known to be free from bacterial contamination a further advantage 
over a competitor is gained from the fear that the other product 
could be harbouring pathogens. Finally the injectability lends a 
more scientific aura to the vaccine. While the majority of 
farmers tend to have a much better understanding of agricultural 
science than their counterparts of 25 years ago, there is still a 
certain belief in the "witchcraft of the needle" which farmers 
find more impressive than oral dosing.
Chapter Four describes experiments to investigate the 
usefulness of some plastics as materials for packaging lungworm 
vaccine.
The advantages of using plastic are the lighter weight of 
packaged vaccine for postage and the reduced need for protective 
outer packaging to prevent breakage in transit. The drawbacks 
are the fear of toxic residues from the plastic, the variability 
of successive batches of plastic bottles and the danger that 
static forces built up at filling can lead to larvae adhering to 
the plastic and not being delivered at dosing.
Of various plastics investigated, P.E.T. (polyethylene- 
tetraphthalate) appeared to give the best results. However, 
problems arose with the evenness of filling these bottles on the 
unadapted Dictol production line and further investigation would 
be required before any conclusive recommendation of these bottles 
could be made.
Another suggested method of reducing production and delivery
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costs was that the initial oral dose could be boosted by an 
injection of lungworm antigen in place of the second oral dose. 
Such antigen could be produced at times of the year when Dictol 
is not in production and could be delivered to the farm along 
with the first oral dose thus reducing the postage costs.
The experiment described in Chapter 5 investigated such a 
regime where the second vaccine dose consisted of an injection of 
freeze-dried L3 antigen. This regime gave poor protection 
against challenge (55.4%) and served to highlight the importance 
of the second oral dose.
As is often the case with research, while a certain amount 
of progress has been made a greater amount remains to be done. 
In particular much remains to be done in order to gain a Ministry 
of Agriculture product licence for the sterile oral/injectable 
vaccine. The actual experiments and amount of data needed will 
be a matter for discussion and negotiation with the licencing 
authorities but the general areas of work can be foreseen.
Firstly it is likely that the Ministry will ask for a 
greater amount of sterility data especially with regard to 
viruses. Before this is done it would be useful to decide at 
what point dichlorophen is going to be introduced into the 
production process. This would enable experiments to be 
performed which directly reflect conditions on the production 
line.
Further protection trials should also be performed. To 
date, only a modest number of calves have been vaccinated with 
the sterile oral or sterile injectable vaccine. The actual 
number of calves required to satisfy the Ministry will need to be
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assessed in order that experiments can be planned that will meet 
their approval. It is also probable that the vaccine will have 
to be tested under conditions of field challenge. Field trials 
will have two aims. Firstly to prove efficacy against a known 
level of field challenge. This will probably be on experimental 
paddocks artificially seeded with lungworm larvae. The second 
aim will be to have the vaccines used on a large number of calves 
by farmers on their own farms. This will determine the safety 
and acceptability of the sterile injectable vaccine under normal 
farming conditions.
In addition further protection trials should be performed 
with various ages of vaccine in order to determine the shelf-life 
of the sterile products.
With regards to the use of the injectable vaccine, in all 
these experiments it will be essential that the vaccine be 
packaged in as near as possible to its final form.
The question of packaging is one of the major problems still 
to be solved. A multidose package is an attractive idea but 
probably not realistic due to the speed at which larvae in 
suspension sediment. It is also likely that a system whereby the 
same needle can be used for more than one animal is unlikely to 
find favour with the licensing authorities since it could be 
implicated in the spread of diseases such as Infectious Bovine 
Leucosis.
This leads to the conclusion that the best answer is single 
dose, prefilled, syringes packed with needles already fitted. 
However, this reintroduces the questions posed in Chapter Four of
137
the advantages of glass versus plastic as a packaging material. 
It is only fairly recently that the technology has been available 
to make small P.E.T. bottles (Lovatt, Glaxo Operations, personal 
communication) and it is currently unlikely that P.E.T. syringes 
could be readily obtained.
Single dose glass prepacked syringes are already used 
for many human viral vaccines (e.g. Fluvin, Evans) although these 
tend to be small (0.5ml.) and are probably not sturdy enough for 
farm use.
A study similar to that of Chapter Four will have to be 
undertaken on various types of syringe and needle in order to 
determine a suitable combination.
The costs of introducing and marketing a new form of vaccine 
will inevitably be high and obviously commercial considerations 
will need to be taken into account in the final decision whether 
the introduction of a sterile injectable vaccine is desirable.
One such consideration is the recent finding that ivermectin 
is a very efficient drug for treating lungworm infections and 
that anthelmintic activity against invading D.viviparus larvae is 
retained for up to 28 days after dosing (Armour, Bairden, Batty, 
Davison & Ross, 1985). This has led to the suggestion (Taylor, 
Mallon & Kenny, 1985) that prophylactic use of ivermectin could 
make lungworm vaccination obsolete and eventually eradicate husk. 
However, this has been questioned (Bain & Urquhart, 1986) on the 
grounds that it is not yet known if calves treated 
prophylactically in this way are immune to challenge in their 
second grazing season. In addition it is probably ill advised to 
use one drug repeatedly to the exclusion of all others thus
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increasing the risk of anthelmintic resistance arising in the 
worm population.
It also seems unlikely that husk can ever be totally 
eradicated. Low levels of pasture challenge can quickly cause 
clinical husk and there is ample evidence to suggest that the 
windborne spores of the fungus Pilobolus can spread the larvae 
efficiently from field to field and farm to farm. Furthermore, 
if eradication of husk was achieved by repeated use of 
ivermectin, then the subsequent generations of calves would be 
completely susceptible to husk should they be moved onto an 
infected pasture. It would seem, therefore, that, in the 
foreseeable future there will still be a considerable need for an 
effective lungworm vaccine.
Looking further ahead, it has always been appreciated that a 
sterile, live, injectable vaccine can only be a stop-gap on the 
way to an improved vaccine.
Possibly the next step in this process should be to 
investigate the continuous in-vitro cultivation of Dictyocaulus 
viviparus. This was attempted by Silverman in the late 1960's 
(reviewed in Silverman, 1965) but recent advances, especially in 
cell culture techniques now make this a more realistic goal. The 
advantages of in-vitro cultivation are three-fold. Firstly, it 
eliminates the need for the numerous culture calves at Bury Green 
and Lady Hayes Farms. Secondly, it would enable the larvae to be 
produced aseptically and could make the use of dichlorophen 
redundant. Thirdly, and most importantly for future vaccine 
development, it would make all stages of the life cycle available
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for research towards a killed vaccine, since at present only 
adult and L 3 antigens can be used in any quantity as 
experimental antigen for immunological studies.
It has always been presumed that lungworm vaccine works by 
presenting the right antigen to the host, in other words, the 
right stage of the worms' parasitic life. Presenting the wrong 
antigen is at best ineffective or at worst causes an allergic 
reaction as was suggested when Jarrett et al. (1960b) used adult 
D.viviparus homogenate to vaccinate calves. The animals in this 
case were probably immune only to adult antigen and when this was 
presented in large quantities in the lung in the challenge 
infection, a very potent immune response was elicited. While 
this did in fact kill the worms, the nature of the response was 
such that severe respiratory distress resulted.
Perhaps, then, in order to stimulate protective immunity 
without causing any adverse allergic response it would be 
possible to use an antigen derived from the L4 or L5 . If such an 
antigen was isolated, it could then be synthesised in large 
quantities using recombinant DNA technology and used as a 
vaccine. However, the production of an effective synthetic 
vaccine could possibly involve the incorporation of several 
different antigens in order to stimulate sufficent immunity.
More importantly, the antigen may have to be presented to a 
particular site. At present the larvae efficiently carry the 
antigen to the mesenteric lymph nodes and on to the lungs. It is 
possible that antigen is taken up by antigen presenting cells 
(APC) and that plasma cells at a particular site need to 
recognise the antigen in conjunction with the cell surface
140
antigens of the APC. With the knowledge that lymphocytes 
recirculate to their own particular location it may be that to 
elicit an efficient immune response to developing worms in the 
mesenteric lymph nodes or lung it is necessary to present the 
antigen at these sites. At present, the art of antigen targeting 
is not advanced enough to make this a feasible proposition. 
However, the experiment of Jarrett et al. (1960b) reported above 
suggests that parenterally introduced antigen can in fact elicit 
a very effective immune reaction in the lung.
The immune response to lungworm infection would appear to 
involve a humoral and a cell mediated component, but until 
recently, studies on vaccination against helminth parasites have 
been preoccupied with humoral responses, the emphasis being on 
producing a clearly defined antigen and eliciting a specific 
antibody response. It is probably necessary to look in greater 
detail at the cell mediated component of the response and at ways 
in which this can be enhanced or initiated to coincide with the 
adminstration of the antigen.
The understanding of immunology has come a long way since 
the concept of an irradiated larval lungworm vaccine was first 
envisaged thirty years ago. The techniques and knowledge are 
probably now available to study the immune response to 
vaccination in sufficient detail to determine the protective 
mechanisms involved. Once these are known it may be possible to 
manufacture a synthetic vaccine. In addition, the understanding 
of this very effective immune response could shed light on ways 
in which less efficient responses (for example that to
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Ostertagia) could be enhanced.
It now seems that a live injectable lungworm vaccine is a 
feasible proposition. However, should such a vaccine be produced 
and no subsequent follow-up research performed, a great 
opportunity would be lost to make a breakthrough in nematode 
vaccination.
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Glass Bottles (2 weeks)
Values for the number of larvae in each 1 ml. aliquot.
Bottle Aliquot number
no. 1 2
1 59 65
2 75 71
3 66 78
4 63 66
5 55 54
6 72 68
7 67 61
8 65 74
9 71 52
10 74 72
11 60 64
12 62 76
13 81 56
14 74 63
15 67 62
16 64 66
17 60 78
18 79 72
19 74 72
20 66 74
3 4 5
72 47 66
45 54 71
65 79 85
68 69 56
73 56 82
68 76 59
63 53 75
48 61 66
72 63 77
62 60 72
74 64 63
60 77 69
65 71 68
61 73 69
75 53 84
64 77 60
73 61 73
74 78 55
97 94 98
77 79 61
mean
61.8
63.2
74.6
64.4
64.0
68.6
63.8
62.8
67.0
68.0
65.0 
68.8
68.2
68.0 
68.2 
66.2
69.0 
71.6
87.0
71.4
Glass bottles (aliquot counts continued) 
Bottle Aliquot number
no. 1 2
21 78 60
22 62 69
23 62 73
24 81 56
25 81 76
26 70 70
27 85 63
28 70 66
29 43 62
30 72 79
31 55 54
32 82 69
33 69 86
34 81 51
35 57 66
36 75 59
37 66 58
38 57 66
39 63 70
40 55 71
41 48 61
42 82 55
43 59 88
3 4 5
85 63 69
62 69 65
79 78 65
74 69 89
62 51 80
67 70 69
69 68 67
71 63 63
65 51 72
71 54 58
57 77 66
65 58 60
66 73 78
65 72 59
57 73 57
71 70 66
61 75 75
65 78 71
61 50 72
57 73 85
68 59 61
84 71 78
54 66 49
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mean
71.0
65.4
71.4
73.8
70.0
69.2
70.4 
66.6
58.6
66.8 
61.8 
66.8
74.4
65.6
62.0
68.2
67.0
67.4
63.2
68.2
59.4
74.0 
63.2
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Glass Bottles (aliquot counts continued)
Bottle
no. 1 2
Aliquot number 
3 4 5
mean
44 57 57 78 72 69 66.6
45 66 64 59 62 84 67.0
46 76 67 67 52 72 66.8
47 71 49 82 72 65 67.8
48 62 62 68 71 54 63.4
49 61 54 70 62 67 62.8
50 73 70 71 74 79 73.4
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P.E.T. Bottles at 2 weeks.
Values for the number of larvae in each 1 ml. aliquot.
Bottle Aliquot number
no. 1 2
1 57 65
2 87 83
3 76 62
4 56 72
5 70 74
6 65 61
7 78 62
8 70 74
9 80 76
10 76 91
11 70 62
12 84 67
13 68 62
14 84 63
15 61 54
16 76 80
17 77 63
18 74 75
19 83 55
20 67 57
27 72 69
28 67 73
3 4 5
59 65 79
67 70 72
42 71 86
68 60 67
62 90 76
66 62 61
64 78 62
79 76 70
78 87 66
70 71 75
72 66 72
77 72 70
61 64 66
59 68 70
81 69 73
70 62 77
73 77 64
70 85 75
66 57 68
49 68 60
65 86 68
61 65 75
mean
65.0
75.8
67.4
64.6
74.4
63.0
68.8
73.8
77.4
76.6
68.4
74.0
64.2
68.8
67.6
73.0
70.8
75.8
65.8
60.2
72.0 
68.2
P.E.T.Bottles 2 weeks (aliquot counts continued).
Bottle
no. 1
Aliquot number 
2 3 4 5
mean
29 59 80 67 56 75 67.4
30 69 79 76 75 88 77.4
31 71 57 75 79 87 73.8
32 63 68 63 79 72 69.0
33 70 64 73 71 57 67.0
34 61 69 74 55 74 66.6
35 60 67 62 61 54 60.8
36 65 57 51 55 72 60.0
37 64 62 69 64 65 64.8
38 62 74 86 72 64 71.6
39 74 68 67 79 69 71.4
40 66 75 81 78 56 71.2
41 75 69 59 78 72 70.6
42 64 67 74 56 60 64.2
43 79 75 71 80 52 71.4
44 96 85 66 60 73 76.0
45 88 74 66 75 81 76.8
46 58 59 58 64 67 61.2
47 86 66 77 72 64 73.0
48 73 62 78 71 56 68.0
49 82 73 55 51 61 64.4
50 64 72 65 68 68 67.4
51 79 83 89 80 72 80.6
P.E.T. Bottles 2 weeks (aliquot counts continued) •
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Bottle
no. 1
Aliquot number 
2 3 4 5
mean
52 54 79 63 61 74 66.2
53 79 55 71 65 79 69.8
54 64 79 84 71 70 73.6
55 77 64 75 71 67 70.8
56 80 65 69 57 59 66.0
57 - 72 63 58 75 73 68.2
58 59 61 73 59 65 63.4
59 91 68 56 91 74 76.0
60 75 65 74 79 58 70.2
61 73 65 63 65 79 69.0
62 92 80 78 57 69 75.2
63 75 66 83 77 76 75.4
64 71 78 91 66 64 74.0
65 71 58 67 90 83 73.8
66 72 69 74 90 65 74.0
67 75 55 74 65 59 65.6
68 63 73 70 68 66 68.0
69 71 67 71 74 69 70.4
70 57 74 83 73 80 73.4
71 66 51 78 66 92 70.6
72 79 76 84 65 66 74.0
73 57 77 72 87 73 73.2
74 81 75 58 76 79 73.8
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P.E.T.Bottles 2 weeks (aliquot counts continued).
Bottle
no. 1
Aliquot number 
2 3 4 5
mean
75 73 64 78 72 54 68.2
76 72 53 58 64 63 62.0
77 72 64 67 68 56 65.4
78 51 64 64 79 75 66.6
79 61 54 85 72 79 70.2
80 62 67 '69 89 62 69.8
81 55 68 62 65 76 65.2
82 81 78 . 86 64 80 77.8
83 70 77 93 74 80 78.8
84 69 51 72 69 72 66.6
85 69 65 68 74 56 66.4
86 61 86 69 71 58 69.0
87 76 74 82 93 60 77.0
88 52 64 70 71 67 64.8
89 82 72 64 81 62 72.2
90 67 67 74 72 62 68.4
91 77 65 77 55 83 71.4
92 61 84 75 70 76 73.2
93 83 71 72 69 83 75.6
94 70 62 72 64 66 66.8
95 83 72 66 70 50 68.2
96 62 76 74 61 81 70.8
97 67 66 63 72 69 67.4
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P.E.T. Bottles 2 weeks (aliquot counts continued) •
Bottle
no. 1
Aliquot number 
2 3 4 5
mean
98 64 65 68 69 74 68.0
99 68 84 67 65 59 68.6
100 53 66 75 77 51 64.4
101 71 66 61 81 52 66.2
102 64 73 81 66 67 70.2
103 91 80 66 66 61 72.8
104 79 64 64 54 49 62.0
105 75 77 58 85 83 75.6
106 77 88 91 74 70 80.0
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Glass Bottles at 5 weeks.
Values for the number of live larvae in each 1 ml. aliquot. 
Bottle Aliquot number mean
64.8
67.2
70.2 
68.6
61.8
65.4
67.4
64.2 
67.0
67.4
67.6
69.4
68.4
74.6 
66.8
64.2
64.8
69.4
60.8
71.4
66.4
71.6
no. 1 2 3 4 5
201 75 53 62 72 62
202 63 66 66 79 62
203 71 75 77 66 62
204 68 73 68 70 64
205 68 48 61 68 64
206 59 68 64 76 60
207 68 80 70 59 60
208 62 65 63 72 59
209 67 66 77 68 57
210 69 62 67 81 58
211 72 66 67 67 66
212 72 58 66 77 74
213 70 69 64 73 66
214 67 70 85 70 81
215 72 59 68 62 73
216 70 66 61 58 66
217 70 51 77 64 62
218 67 65 71 64 80
219 58 56 67 59 64
220 69 84 71 68 65
221 53 70 67 63 79
222 73 73 76 79 57
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Glass Bottles 5 weeks (aliquot counts continued)
Bottle
no. 1
Aliquot number 
2 3 4 5
mean
223 76 71 66 71 73 71.4
224 51 64 68 64 59 61.2
225 60 66 79 65 68 67.6
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P.E.T. Bottles at 5 weeks.
Values for the number of live larvae in each 1 ml. aliquot.
Bottle Aliquot Number
no. 1 2 3 4 5
201 41 42 46 37 41
202 55 66 44 62 67
203 42 45 38 48 43
204 60 55 62 73 72
205 59 63 61 65 67
206 36 49 43 49 54
207 54 65 62 67 61
208 75 78 75 71 68
209 88 62 60 80 65
210 61 69 61 74 71
211 57 71 71 64 76
212 48 38 63 46 32
213 55 57 60 53 64
214 53 60 52 64 82
215 73 44 73 54 65
216 70 62 67 72 85
217 71 75 58 56 60
218 85 63 54 69 69
219 55 49 59 50 61
220 63 67 73 44 66
221 68 53 46 55 58
222 58 55 68 65 58
mean
41.4
58.8
43.2
64.4
63.0
46.2
61.8
73.4
71.0
67.2
67.8
45.4
57.8
62.2
61.8 
71.2
64.0
68.0
54.8 
62.6 
56.0
60.8
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P.E.T. Bottles 5 weeks (aliquot counts continued)
Bottle Aliquot number mean
no. 1 2 3 4 5
223 71 76 69 78 55 69.8
224 86 74 72 80 81 78.6
225 73 60 57 70 74 66.8
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Glass Bottles at 5 Weeks.
Values for the number of dead larvae in each 1 ml. aliquot
Bottle Aliquot Number
no. 1 2 3 4 5
201 3 4 3 1 3
202 4 5 7 2 3
203 5 6 7 4 3
204 3 1 5 2 1
205 1 3 4 2 2
206 3 1 2 1 1
207 2 7 3 5 8
208 4 3 6 1 7
209 1 3 2 5 1
210 3 2 3 4 2
211 4 5 1 7 3
212 3 3 4 4 2
213 4 1 3 1 3
214 2 6 1 1 1
215 2 3 2 0 5
216 3 5 6 7 6
217 8 6 6 4 0
218 2 1 4 1 2
219 3 5 8 1 3
220 3 1 5 2 4
221 3 3 3 4 5
222 5 6 1 0 0
Mean
2.8
4.2
5.0
2.4
2.4 
1.6
5.0
4.2
2.4 
2.8
4.0
3.2
2.4
2.2
2.4
5.4 
4.8
2.0
4.0
3.0 
3.6
2.4
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Glass Bottles at 5 weeks (aliquot counts continued).
Bottle Aliquot Number
no. 1 2 3 4 5
223 2 3 8 4 2
224 3 2 6 3 8
225 3 2 1 2 1
mean
3.8 
4.4
1.8
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P.E.T. Bottles at 5 weeks.
Values for the number of dead larvae in each 1 ml. aliquot
Bottle Aliquot Number
no. 1 2 3 4 5
207 6 2 8 3 2
208 3 7 7 6 4
209 6 3 6 6 0
210 5 4 2 1 2
211 3 0 5 2 1
212 3 1 4 2 4
213 7 2 3 4 3
214 3 2 2 2 3
215 3 1 4 1 4
216 4 6 3 1 2
217 2 5 4 3 4
218 4 6 3 2 3
219 4 4 2 5 4
220 6 6 3 5 4
221 4 3 3 1 3
222 4 ' 4 7 4 3
223 2 3 2 6 4
224 6 5 5 1 7
225 3 3 4 2 2
mean
4.2
5.4
4.2 
2.8
2.2 
2.8
3.8
2.4 
2.6 
3.2
3.6
3.6
3.8
4.8
2.8
4.4
3.4
4.8
2.8
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Total Volume of vaccine contained in each of 25 glass bottles 
(ml.).
23.4 23.6 23.8 23.8 23.8
23.8 23.8 24.0 24.0 24.0
24.0 24.0 24.0 24.2 24.2
24.2 24.2 24.4 24.4 24.4
24.4 24.6 24.6 24.6 24.6
Total volume of vaccine contained in each of 25 P.E.T. bottles 
(ml.).
18.8 19.2 19.2 19.2 19.2
19.4 19.4 19.4 19.6 19.6
20.2 21.2 21.4 21.6 21.6
21.8 21.8 22.0 23.8 23.8
24.0 24.0 24.0 24.0 24.0
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Proof that all above data display normal distributions.
1. Glass bottles 2 weeks
> 95% must lie in mean _+ 2.01 x standard deviation
= 67.48 + (2.01 x 4.72)
= 67.48 + 9.49 
= 57.99 to 76.97 
1 sample out of 50 lies outwith this range = 98% within. 
Therefore these figures display a normal distribution.
2. P.E.T. bottles at 2 weeks
> 95% must lie in mean _+ 1.99 x standard deviation
= 69.94 + (69.94 x 4.68)
= 69.94 + 9.31
= 60.6 to 79.25
4 samples out of 100 lie outwith this range = 96% within 
Therefore these figures display a normal distribution.
3. Glass bottles, live larvae at 5 weeks.
> 95% must lie in mean +_ 2.06 x standard deviation
= 67.2 + (2.06 x 3.37)
= 67.2 + 6.94
= 60.3 to 74.1
1 sample out of 25 lies outwith this range = 96% within.
Therefore these figures display a normal distribution.
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4. P.E.T. bottles, live larvae at 5 weeks.
> 95% mast lie in mean _+ 2.06 x standard deviation.
= 61.5 + (2.06 x 9.53)
= 61.5 + 19.63 
= 41.9 to 81.2 
1 sample out of 25 lie outwith this range = 96% within. 
Therefore these figures display a normal distribution.
5. Glass bottles, dead larvae at 5 weeks.
> 95% must lie in mean +_ 2.06 x standard deviation
= 3.3 + (2.06 x 1.12)
= 3.3 + 2.31 
= 1.0 to 5.6
No samples lie outwith this range = 100% within. 
Therefore these figures display a normal distribution.
6. P.E.T. bottles, dead larvae at 5 weeks.
> 95% must lie in mean _+ 2.11 x standard deviation
= 3.6 + (2.11 x 0.90)
= 3.6 + 1.90 
= 1.7 to 5.5
No samples lie outwith this range = 100% within. 
Therefore these figures display a normal distribution.
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7. Glass bottles, total volumes per bottle.
> 95% must lie in meanf 2.06 x standard deviation
= 24.1 + (2.06 x 0.33)
= 24.1 + 0.68
= 23.4 to 24.8 
No samples lie outwith this range = 100% within. 
Therefore these figures display a normal distribution.
8. P.E.T. bottles, total volumes per bottle
> 95% must lie in mean +_ 2.06 x standard deviation
= 21 .3 + (2.06 x 1.96)
= 21.3 + 4.04
= 17.3 to 25.3 
No samples lie outwith this range = 100% within. 
Therefore these figures display a normal distribution.
Appendix to Chapter Seven.
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Virology Materials & Methods.
Samples of bovine herpesvirus (BHV) type-1 (infectious 
bovine rhinotracheitis virus) and bovine viral diarrhoea virus 
(BVDV) were added to the Dictyocaulus preparation and processed 
as for vaccine production. A sample of each was then taken and 
assayed for viral infectivity together with samples of the 
original, unprocessed virus stock. To a volume of 0.4ml of the 
vaccine was added 1 ml. of 10x concentrated phosphate buffered 
salin to restore the sample to isotonicity. The samples were 
stored at -70°C before assay.
Bovine herpesvirus.
BHV infectivity was titrated in a plaque assay using a line 
of bovine conjunctival cells in 6-well cluster plates (Nunc).
/r
The plates were seeded with 1 x 1 0  cells per well 24 hours
previously. The medium was then replaced with 1.0ml of the
sample in a range of dilutions from undiluted to 1:5. The
—7 —1untreated sample was diluted 10 to 10 in medium. The samples 
were incubated at 37°C for 3 hours. The inocula were then 
removed, the cell sheet was washed with medium and an overlay of 
medium with 1% agarose was added. The plates were incubated at 
37°C for 3 days when the overlay was removed and the cells were 
stained with 1% crystal violet in 5% methanol and 10% formalin. 
The resulting plaques were counted.
n
The titre of the untreated sample was 2.0 x 10 plaque 
forming units (pfu) per ml. No virus was detected in the vaccine 
at a dilution of 1:5 which was the lowest dilution which did not 
lyse the cells.
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Bovine viral diarrhoea virus.
Test virus was the cytopathic NADL strain of BVD virus 
(Gutekunst and Malmquist, 1963) derived from the American type 
culture collection (ATOC VR-543), and received from Dr. P. Roeder 
CVL Weybridge at the 7th passage level in bovine cells (BEK and 
bovine turbinate). After two further passages in BEK cells the 
virus was purified three times and a stock was established at the 
13th passage level.
The plague assay procedure was based on that described by 
Lande and Gelfi (1979). Confluent monolayers of bovine embryonic 
testis cells in 12 well Linbro plastic plates (Flow) were washed 
three times with Hanks BSS and inoculated with 0.2ml of dilution 
of virus. After two hours adsorption at 37°C the inocula were 
removed and all wells received 2ml of "199" medium supplemented 
with BSA (0.5%), lactalbumin hydrolysate (0.1%), yeast extract 
(0.1%) and heat-inactivated horse serum (3%), and containing 100 
iu/ml penicillin, 100ug/ml streptomycin, 2ug/ml amphotericin B 
deoxycholate and 0.6% agarose. Four days later, cells were fixed 
with 10% formol saline and stained with 1% (w/v) crystal violet 
in 20% (v/v) ethanol in distilled water.
The titre of the untreated sample was 1.3 x 10^  pfu/ml. No 
virus was detected in a 1:5 dilution of the vaccine.
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